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ABSTRACT 
 
Three studies were conducted to determine the arginine (Arg) sparing effect of 
guanidinoacetic acid (GAA) and the efficacy of GAA to support growth performance and muscle 
phosphagen homeostasis in chicks when supplemented in either Arg-deficient or Arg-adequate 
diets.  Study 1 established that 0.12% GAA supplementation increased (P < 0.05) gain:feed 
(G:F) by 7% on average compared with the 0.0% GAA negative controls.  Bodyweight gain 
(BWG) increased (P < 0.05) and G:F (P < 0.05) for d 15 to 22 and d 8 to 22 with increasing Arg 
and GAA supplementation, proving that diets were successfully Arg deficient, and Arg and GAA 
supplementation alleviated the deficiency. Muscle metabolites, including phosphocreatine (PCr) 
and PCr:ATP, were increased (P < 0.05) by an average of 101% and 103%, respectively, with 
0.12% GAA compared with the 0.0% GAA negative controls. Total Cre (tCre) was increased 
(Arg and GAA interaction, P < 0.05) by 41 and 51% with 0.12% GAA when included in diets 
containing 0.0 or 0.16% added Arg, respectively. Hematological and clinical chemistry outcomes 
were unaffected by GAA treatment, and plasma concentrations of essential amino acids appeared 
to be reflective of improvements in growth performance. Study 2 confirmed that 0.12% GAA 
supplementation increased (P < 0.05) BWG and G:F (P < 0.05) from d 0 to 28 by 6 and 8%, 
respectively, when compared with the negative control diet. Muscle concentrations of both PCr 
and tCre were increased (P < 0.05) with addition of 0.12% GAA by 66 and 49%, respectively, 
compared with the negative control (Arg-deficient). In Study 3, 0.12% GAA supplementation 
increased (P < 0.05) G:F d 14 to 27 by 3% when compared with the negative control (Arg-
adequate) diet. Muscle PCr and tCre concentrations were also increased (P < 0.05) in chicks 
receiving 0.12% supplemental GAA by 26 and 18%, respectively, as compared with the negative 
iii 
 
 
control (Arg adequate). Improvements in growth performance and muscle phosphagen 
concentrations in broiler chicks consuming practical diets supplemented with GAA indicates that 
this feed additive is a suitable replacement for Arg. 
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Chapter 1
 
INTRODUCTION 
 
Feed constitutes the greatest proportion of costs associated with poultry production, with 
most of that cost related to the high price of protein-furnishing ingredients. As commodity crop 
prices rise due to poor weather conditions, increased demand for products, and alternative land-
usage, poultry producers increasingly look for alternative feed ingredients to use as substitutes. 
These alternative feed ingredients can be categorized as co-products, by-products, and non-
traditional feed ingredients. However, these alternatives may have lower quality and higher 
variability of protein and amino acid concentrations compared with the original sources. This 
variability can be addressed with supplementation of commercially-available, crystalline amino 
acids. Unfortunately, not all amino acids are commercially available; an example that is not 
readily available is arginine (Arg). Arginine is the fifth limiting essential AA in most poultry 
diets and is needed for mainly bodily functions concerning maintenance (i.e., creatine 
production) and growth (i.e., protein synthesis) (Klose et al., 1938; Waguespack et al., 2009; Wu 
and Morris Jr., 1998). Due to the increased growth rate of modern broilers (Havenstein et al., 
2003), lack of Arg de novo synthesis (Tamir and Ratner, 1963), and bodily need for Arg-based 
metabolites (i.e., Cre) (Walker, 1979), dietary Arg supplementation may be required to support 
optimal growth and maintenance (Han et al., 1992). Without an economically-feasible and 
commercially-available source of Arg, the increased use of lower crude protein formulations and 
alternative ingredients, including distillers dried grains with solubles (DDGS), necessitates the 
inclusion of crystalline AA beyond those which are currently available. Therefore, the poultry 
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industry may soon have a need to supplement Arg, and one way to relieve the formulation 
pressure may be providing a feed additive that can spare the use of Arg for Cre synthesis. 
Guanidinoacetic acid (GAA) is a compound formed from Arg and Gly, and is produced via 
chemical synthesis from glycine cyanamide commercially as CreAMINO®. Guanidinoacetic acid 
is able to spare Arg that would otherwise be used for Cre synthesis (Savage and O'Dell, 1960) 
because it is converted into Cre in both the avian liver and kidney (Van Pilsum et al., 1972). 
Creatine is used to make the high-energy phosphagen PCr and assists in maintaining energy 
homeostasis in muscles (Guimarães-Ferreira, 2014). If supplemented as an Arg replacement 
(Dilger et al., 2013), GAA has been reported to both spare Arg in Arg-deficient diets, but also to 
improve growth performance in Arg-adequate diets (Michiels et al., 2012). If the cost of GAA is 
less expensive than, or equal to, commercially available Arg, then GAA supplementation would 
be more advantageous to supplement because of the improvement observed in Arg-adequate 
diets. Therefore, the poultry industry may choose to use GAA as an Arg replacement, relieving 
the necessity for Arg supplementation in current poultry diets. 
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Chapter 2 
 
 
LITERATURE REVIEW 
 
Arginine (Arg) is needed for maintenance and growth in vertebrates and is required for 
the synthesis of nitric oxide, creatine (Cre), the non-essential amino acids proline and glutamate, 
and for protein synthesis (Wu and Morris Jr., 1998). Synthesis of muscle protein and production 
of Cre are particularly important for young, growing animals due to the high rate of muscle and 
nerve growth that occurs (Walker, 1979). Because the bodily need for Arg is so high during this 
phase of increased growth, Arg is considered semi-essential in mammals and essential in poultry 
and reptiles (Klose et al., 1938). Commercial poultry, in particular broiler chickens, have been 
bred for increased rates of growth and muscle development, reaching production size between 6 
and 8 weeks of age. Because of the increased rate of growth for current broiler chickens, which 
increases growth and maintenance requirement for Arg, and due to the limitations of chickens to 
synthesize Arg de novo (Klose et al., 1938; Tamir and Ratner, 1963a), supplemental dietary Arg 
may be required to support optimal growth and maintenance (Han et al., 1992). 
Arginine Metabolism 
Due to the insufficient capacity for de novo Arg production, chickens require twice as 
much Arg as pigs as proportion of the diet. During the swine grower phase, the National 
Research Council (NRC) Arg requirement is 0.50% to 0.32% of the diet, while during the same 
period in broiler chickens, the NRC Arg requirement is 1.1% of the diet (NRC, 2012; NRC, 
1994). This difference in requirement is because pigs, like other mammals, are capable of 
producing a sizeable proportion of their required Arg de novo.  
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Arginine Synthesis 
 In mammals, Arg synthesis occurs via the culmination of multiple metabolic pathways. In 
mature animals, the major precursor for Arg synthesis is citrulline (Cit) produced in the small 
intestine (De Jonge et al., 1998; Herzfeld and Raper, 1976; Hurwitz and Kretchmer, 1986; Wu, 
1998), with glutamine and glutamate serving as the major Cit precursors (Matthews et al., 1993; 
Stoll et al., 1998; Windmueller and Spaeth, 1975; Wu, 1998). Citrulline is transported from the 
small intestine to the kidney where argininosuccinate synthase (AS) and argininosuccinate lysase 
(AL) convert Cit to Arg (Figure 2.1), accounting for nearly 60% of net Arg synthesis in 
mammals (Dhanakoti et al., 1990; Funahashi et al., 1981; Levillain et al., 1992; Wu and Morris 
Jr., 1998). 
 Although, Arg is synthesized as part of the urea cycle in mammals, it is immediately 
converted to ornithine (Orn) and urea, thereby continuing the cycle with no net synthesis of Arg 
(Morris Jr., 1992; Wu and Morris Jr., 1998). It was theorized, however, that net Arg synthesis 
could occur if it was maintained through the introduction of intermediates, like Orn from other 
sources (Wu and Morris Jr., 1998), such as the production of guanidinoacetic acid (GAA) 
(Brosnan and Brosnan, 2010). The production of GAA would continue the urea cycle by 
converting Arg and glycine (Gly) to Orn and GAA via the enzyme arginine:glycine 
amidinotransferase (AGAT), with Orn returning to the cycle to be converted to Arg again 
(Figure 2.2). In rats, McGuire et al. (1986) were able to detect AGAT protein not only in the 
kidney of the rat, but also in the hepatocytes, thus prompting further study of Cre synthesis in the 
kidney. Incubating rat hepatocytes with isotope-labeled ammonia, along with Gly, methionine 
(Met), and pyruvate, Brosnan and Brosnan (2010) reported no detectable levels of Cre, though it 
was previously demonstrated that rat hepatocytes could convert labeled ammonia to labeled urea, 
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and GAA to Cre (da Silva et al., 2009). Because there was no detectable production of Cre in rat 
hepatocytes when incubated with GAA precursors and stimulation of the urea cycle, it was 
concluded that AGAT was not producing GAA with Arg from the urea cycle. 
 Unlike mammals, birds and other uricotelic animals excrete nitrogen as uric acid via the 
“urate cycle” (Campbell, 1995). Development of uric acid excretion, as well as formation of the 
bird’s cloaca, is theorized to have begun due to an increasingly arid environment during the late 
Triassic period (Benton, 1983). The arid environment pushed for the conservation of water as a 
means of survival, and thus the evolution of the avian kidney has allowed for the excretion of 
nitrogenous waste as a semi-solid paste resulting in little water excretion via the production of 
uric acid (Laverty and Skadhauge, 2008; Schmidt-Nielsen, 1988). Uricogenesis is the excretion 
of nitrogen, through the breakdown of purines, as uric acid or urate. This process uses fifteen 
enzymatic steps to recycle ribose-5-phosphate and synthesize urate (Campbell, 1995) (Figure 
2.3). The major enzymes that are important in uric acid production include glutamine synthetase 
(GS) and xanthine dehydrogenase (XDH). Glutamine synthetase is used to fix ammonia; it is the 
uricotelic equivalent of mammalian carbamylphosphate synthetase I (CPS-I) (Campbell, 1995). 
Xanthine dehydrogenase is the final enzyme in the production of uric acid; it is a source of 
reduced nicotinamide adenine dinucleotide (NADH) for uricogenesis (Campbell, 1995). 
 Although chickens and other uricotelic animals do not excrete nitrogen via the urea cycle, 
enzymes integral to this cycle are present in various organs in the chicken. While only low levels 
of arginase activity are observed in chicken liver, both AS and AL are present in the chicken 
kidney (Tamir and Ratner, 1963a). The activity of renal AS and AL in chickens was determined 
to be similar to that observed in rats, 10 μg AS·h-1·g-1 kidney tissue wet weight and 11 μg AL·h-
1·g-1 kidney tissue wet weight vs. 22 μg AS·h-1·g-1 kidney tissue wet weight and 16 μg AL·h-1·g-1 
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kidney tissue wet weight (Tamir and Ratner, 1963a). Because both of these enzymes are present 
in the kidney, Cit is able to replace Arg in chicks (Klose et al., 1938; Tamir and Ratner, 1963b). 
Tamir and Ratner (1963b) conducted a study to prove the conversion of Cit to Arg in the kidney 
by feeding labeled Cit to chicks fed a low Arg diet. Labeled Arg was observed in organs, blood, 
and muscle tissues, proving the conversion of Cit to Arg was possible with approximately 30% 
efficiency. Although Cit can be converted to Arg in birds, similar to mammals, Cit cannot be 
synthesized de novo, as in mammals. Tamir and Ratner (1963b) conducted an additional study to 
determine if Cit could be synthesized in the chicken, not just converted to Arg. Chickens fed a 
low Arg diet were supplemented with unlabeled Cit and 14C labeled sodium carbonate. These 
authors theorized that if ornithine transcarbamoylase (OTC) was present in the chicken, any 
carbamoyl phosphate containing the 14C label would be detectable as labeled Cit. Although 
labeled 14C was observed in glutamic acid and aspartic acid pools, no labeled Arg was measured, 
indicating that Cit could not be formed by the action of OTC in the chicken. 
 Wu and Flynn (1995) also conducted a study to determine if Cit was synthesized in the 
intestines of the chick. After incubating chick enterocytes in either glutamine or Orn, these 
authors reported that neither Orn, Cit, nor Arg were converted from glutamine, and neither Cit 
nor Arg were synthesized from Orn. To confirm their conclusions, the activities of pyrroline-5-
carboxylate (P-5-C) synthase and OTC were measured, along with many other enzymes 
connected with Cit, Orn, and Arg synthesis. Compared with levels observed in pig enterocytes, 
AS, AL, and arginase levels were lower in chickens, 0.15 ± 0.02, 0.22 ± 0.03, 0.34 ± 0.06 
nmol·min-1·mg-1 protein, respectively vs. 1.72 ± 0.24, 3.01 ± 0.29, 2.28 ± 0.35 nmol·min-1·mg-1 
protein, respectively (Wu et al., 1995). When comparing CPS-I, levels were similar in both 
chickens (1.27 ± 0.06 nmol·min-1·mg-1 protein) and pigs (Wu et al., 1994). However, phosphate-
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dependent glutaminase (PDG) and ornithine aminotransferase (OAT) levels, 1.95 ± 0.37 and 
1.42 ± 0.39, nmol·min-1·mg-1 protein respectively, were lower in chickens as compared with 
pigs, 17% and 3% activity, respectively (Wu et al., 1994). The lower levels of PDG and OAT in 
chickens indicate that glutamine could not be used to synthesize Orn. No activity of either P-C-5 
synthase or OTC were detected in the enterocytes of chickens, confirming observations from the 
in vitro studies. 
Guanidinoacetic Acid Production 
 In all vertebrates, one of the main uses for Arg, from either dietary or de novo origins, is 
the production of GAA, which is the precursor to Cre. Guanidinoacetic acid is synthesized 
through the transfer of an amidino group from Arg to Gly via AGAT, forming GAA and Orn 
(Figure 2.4). This de novo synthesis of GAA accounts for 40-60% of the total Cre in rats 
(Goldman and Moss, 1959), indicating that a large amount of Arg is used for the production of 
GAA in the body.  
 In mammals, the production of GAA occurs mainly in the kidneys, where AGAT activity 
is highest, although small amounts of AGAT have been detected in the liver (Walker, 1979). The 
rat, for example, has AGAT activity of 22.2 μmol GAA·h-1·g-1 kidney tissue, while humans have 
an AGAT activity of 10.4 μmol GAA·h-1·g-1 kidney tissue (Van Pilsum et al., 1972).  In the liver 
however, the AGAT activity in rats is <0.01 μmol GAA·h-1·g-1 liver, while in humans it is 1.0 
μmol GAA·h-1·g-1 liver, indicating that very little GAA is produced in liver compared with 
kidney in mammals. Chickens, on the other hand, are able to synthesize GAA in both the kidney 
and liver, with AGAT activity of 2.5 μmol GAA·h-1·g-1 kidney and 3.5 μmol GAA·h-1·g-1 liver 
(Van Pilsum et al., 1972). Comparatively, enzyme activity of AGAT in the chicken is about 25% 
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of that observed in the human, but the enzyme is more distributed in the chicken than the human. 
The enzyme activity of AGAT is very important for the production of Cre, with AGAT being 
both the limiting reaction for Cre synthesis and the most regulated step (Walker, 1979; Wyss and 
Kaddurah-Daouk, 2000).  
 The rate-limiting nature of AGAT may be related to availability of GAA precursor 
compounds. In rats, although the Km values of AGAT for Gly and Arg are relatively similar (2.4-
2.8 mM and 3.0-3.1 mM, respectively), the renal concentrations of these amino acids are 
extremely different (Brosnan et al., 1983), leading to concentrations that are about 2.5 mM for 
Gly and 0.32 mM for Arg (Edison et al., 2007). These concentration differences indicate that Arg 
is the limiting substrate in production of GAA, which could be problematic if animals were fed 
an Arg-deficient diet. In mammals this is not a concern, as there is ample de novo synthesis of 
Arg. In birds and other uricotelic animals, however, many metabolic consequences could arise, 
such as decreased growth, impaired metabolic functions, and impaired muscle development 
(Wietlake et al., 1954). 
Creatine Metabolism 
Creatine Synthesis 
 Creatine synthesis is the only known metabolic function of GAA (Walker, 1979), and is 
synthesized when GAA receives a methyl moiety from S-adenosylmethionine (SAM) via 
guanidinoacetate methyltransferase (GAMT); S-adenosylhomocysteine (SAH) is released as a 
byproduct of this reaction. Creatine helps to maintain the energy balance in cells and tissues by 
accepting high energy phosphate groups from adenosine triphosphate (ATP) to create 
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phosphocreatine (PCr), and then releasing the high energy phosphate group to form ATP when 
energy demand is high (Guimarães-Ferreira, 2014; Wyss and Kaddurah-Daouk, 2000). 
  In mammals, Cre is synthesized primarily in the liver, where GAMT activity is highest, 
although small amounts of GAMT are detectable in the kidney (Walker, 1979). The rat, for 
example has GAMT activity of 0.77 μmol Cre·h-1·g-1 liver, while humans have GAMT activity 
of 0.85 μmol Cre·h-1·g-1 liver (Van Pilsum et al., 1972). In the kidney, however, the GAMT 
activity in rats is 0.02 μmol Cre·h-1·g-1, while in humans it is 0.07 μmol Cre·h-1·g-1, indicating 
that little Cre is produced in kidney as compared with liver in mammals. Chickens, on the other 
hand, are able to synthesize Cre in both the kidney and liver, with GAMT activity at 1.21 μmol 
Cre·h-1·g-1 liver and 1.06 μmol Cre·h-1·g-1 kidney (Van Pilsum et al., 1972). 
Phosphocreatine Synthesis 
 Phosphocreatine is formed when an energy rich phosphate group is removed from ATP 
and attached to Cre by creatine kinase (CK) in a reversible reaction (Figure 2.2). The 
phosphorylation cycle of Cre and PCr is incredibly important to energy distribution and for the 
maintenance of energy in cells (Guimarães-Ferreira, 2014).  Creatine kinase facilitates the 
exchange of energy rich phosphate groups between Cre and PCr, thereby using ATP and 
adenosine diphosphate (ADP) as metabolic intermediates (Figure 2.5) (Brosnan and Brosnan, 
2010; Guimarães-Ferreira, 2014; Wyss and Kaddurah-Daouk, 2000). Creatine kinase is 
composed of four isoforms observed in the cytosol of muscles (CK-M) and brain (CK-B), and in 
the mitochondria of muscles and all other tissues (Cit-mit) (Guimarães-Ferreira, 2014; Wyss and 
Kaddurah-Daouk, 2000). It is through the compartmentalization of CK that the PCr “transport” 
or “shuttle” theory is possible (Guimarães-Ferreira, 2014; Wyss and Kaddurah-Daouk, 2000). 
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The “shuttle” theory is the cyclical movement of ATP and ADP through the use of PCr and Cre. 
Beginning with the formation of ATP in the mitochondria, CK-mit cleaves the phosphate from 
ATP forming ADP and PCr. Phosphocreatine, due primarily to size and ease of diffusion 
(Minajeva et al., 1996; Yoshizaki et al., 1990), moves from the mitochondria to the cytoplasm 
where isomers of CK-M or CK-B remove the phosphate group from PCr, forming Cre, and 
regenerating ATP from ADP. The regenerated ATP is converted back into ADP by an ATPase in 
muscle, brain, or other tissues, where the phosphate group is used for metabolic work (e.g., 
muscle contraction). Creatine diffuses back into the mitochondria to be used again in the cycle 
(Guimarães-Ferreira, 2014; Wyss and Kaddurah-Daouk, 2000).  
 Without a functioning PCr “shuttle” system, muscles would be unable to contract. Using 
frog muscles, Cain and Davies (1962) showed that when CK is inhibited, isolated muscle could 
only contract about 10% of that of control muscles (3 muscle contractions vs. > 30 muscle 
contractions), with no measureable difference in PCr before or after contractions. If the “shuttle” 
system were not able to function properly in poultry, then there would be little to no muscle 
growth. Thus, if Cre and PCr concentrations were suboptimal, e.g., due to Arg deficiency, 
muscle growth could be impaired not only because of less Arg for protein accretion, but also due 
to impaired ATP distribution in muscles. 
Creatinine Synthesis 
While converting between Cre and PCr in the PCr “shuttle”, some molecules of both Cre 
and PCr are converted into and excreted as creatinine (Crn) through a non-enzymatic and 
spontaneous reaction (Wyss and Kaddurah-Daouk, 2000). Under in vitro conditions, the 
reversible conversion of Cre to Crn is dependent on both pH and temperature. Low pH and high 
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temperature favors the conversion to Crn, while high pH and low temperature favors the 
conversion to Cre (Kreider et al., 1996). However, this metabolic regulation has not been 
confirmed in vivo, mainly because conversion from Cre to Crn appears to be irreversible (Bloch 
and Schoenheimer, 1939; Walker, 1979). Originally it was theorized that Crn could be converted 
to Cre due to an increase in muscle Cre when Crn was supplemented (Almquist et al., 1941). 
Using labeled Cre and Crn, subsequent studies proved the conversion was irreversible (Bloch 
and Schoenheimer, 1939; Wyss and Kaddurah-Daouk, 2000), with ingestion of labeled Cre being 
quantified as muscle Cre and urinary Crn. When labeled Crn was supplemented, however, the 
labeled isotope was observed mainly in the urine with no significant levels of isotope observed in 
body Cre (Bloch and Schoenheimer, 1939; Wyss and Kaddurah-Daouk, 2000). When studied in 
vivo, it was concluded that 1.1% of endogenous Cre and 2.6% of endogenous PCr were 
irreversibly converted into Crn each day in humans, with an average of 1.7% of total Cre (i.e., 
Cre + PCr) turned over daily (Walker, 1979; Wyss and Kaddurah-Daouk, 2000). 
Regulation of Creatine Production 
 Due to the important roles of Cre and PCr in energy maintenance of brain and muscle 
tissues, the production of Cre is highly regulated (Wyss and Kaddurah-Daouk, 2000), and all 
regulation of this metabolic pathway is due to the AGAT enzyme. 
Arginine:Glycine Amindinotransferase 
 The formation of GAA by AGAT is the rate-limiting, and most highly regulated, step in 
Cre production (Wu, 1998; Wyss and Kaddurah-Daouk, 2000). The primary regulation of AGAT 
is feedback repression by Cre, which causes a decrease in mRNA expression, AGAT 
concentration, and AGAT activity, indicating that Cre regulates AGAT at both transcriptional 
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and translational levels (Guthmiller et al., 1994; Walker, 1979). This down-regulation of AGAT 
can be absolute, although total repression is uncommon. Arginine and GAA are also purported 
regulatory molecules, as both need to be converted to Cre to decrease AGAT activity (Magri et 
al., 1975; Walker and Wang, 1964; Wyss and Kaddurah-Daouk, 2000).  
 The expression of AGAT is also controlled via hormonal influence. Using rats without 
thyroid or pituitary glands, injection of thyroid hormone and growth hormone caused AGAT 
activity to increase until levels were normal (Guthmiller et al., 1994; Van Pilsum et al., 1992). 
Thyroid and growth hormone administration caused an increase in the expression of AGAT level 
and activity, indicating that the hormonal regulation was similar to Cre regulation by influencing 
the level of gene expression (McGuire et al., 1980). However, when growth hormone was 
injected into hypophysectomized rats consuming Cre-supplemented diets, there was no change in 
AGAT activity compared with non-supplemented, hypophysectomized rats. This indicates that 
Cre and growth hormone are antagonistic in regard to AGAT activity (McGuire et al., 1980; Van 
Pilsum et al., 1992). 
In addition to the regulatory effects of Cre on AGAT activity, complete cessation of 
nutrients (i.e., fasting) also influences AGAT (Van Pilsum et al., 1992). Walker (1960) 
discovered that chicks fed a diet with 3% supplemental Cre had a decrease in AGAT activity 
after 3 days of feeding (7.3 μmol GAA·h-1·g-1liver wet weight in control birds compared with 0.5 
μmol GAA·h-1·g-1 liver wet weight in treated birds). Fasting also causes decreased AGAT levels 
due to the increase in blood Cre levels that occurs when an animal is fasted (Kim et al., 1983). 
Although determined first in mice (Kim et al., 1983), Walker (1960) reported similar trends in 
chicks. As was discussed above, chicks fed a diet with supplemental Cre had decreased AGAT 
activity. After receiving a diet supplemented with 2% Cre for 74 h, AGAT levels in chicks 
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decreased to approximately 10% of control levels (17 μmol GAA·h-1·g-1 liver weight wet). At 
that point, the investigators divided the birds into two groups and they were either returned to the 
control diet or given no food (i.e., fasted). After 48 h off of Cre supplementation, chicks returned 
to the control diet had AGAT activity that was about 70% of control levels, indicating a transient 
response to dietary Cre supplementation. However, fasted birds had virtually no AGAT activity 
when compared with birds remaining on the Cre-supplemented diet. Whereas no explanation was 
given in the original manuscript, it is now understood that fasting also increased the circulating 
Cre in the body to inhibit AGAT activity. 
Guanidinoacetic Acid Methyltransferase 
 Unlike AGAT, GAMT expression and activity are not regulated by Cre (da Silva et al., 
2009; Wyss and Kaddurah-Daouk, 2000). Guanidinoacetic acid methyltransferase is consistently 
inhibited by SAH, as are virtually all methyltransferases (Clarke and Banfield, 2001; Fujioka et 
al., 1988). da Silva et al. (2009) reported that GAMT activity in hepatocytes was not affected in 
rats fed either Cre-free or Cre-supplemented diets. More importantly, these investigators reported 
that the rate of conversion of GAA to Cre was not altered with either dietary treatment when 
hepatic cells were incubated with GAA. Therefore, if GAA is supplemented to cells, Cre 
production continues without inhibition. 
Arginine-Sparing Effects 
 With adequate Cre supplementation, AGAT enzyme concentration and activity are 
reduced such that de novo Cre synthesis is decreased or completely repressed (Walker, 1960; 
Wyss and Kaddurah-Daouk, 2000). Because there is no need for GAA formation when Cre is 
supplemented to a diet, the precursors of GAA production and Cre formation are able to be 
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spared for use elsewhere in the body. The sparing of components is only possible because AGAT 
is regulated by the end-product of Cre. In regard to GAA production, both Arg and Gly can be 
used for other functions in the body, such as protein accretion, nitric oxide production, or de 
novo amino acid synthesis. Moreover, in regard to Cre production, methionine and SAM can be 
spared for use in other parts of the body, such as protein synthesis and methylating other 
compounds, respectively. 
Creatine 
 Almquist et al. (1941) reported that supplementing Cre, GAA, or Crn stimulated growth 
of chicks fed Arg-deficient diets, indicating that all compounds exhibited Arg-sparing effects. 
Wietlake et al. (1954) used Cre, Arg, and Gly to determine how best to alleviate Arg deficiency 
in casein-based diets fed to chicks. It was observed that Cre supplementation did improve growth 
rates in chicks fed an Arg-deficient diet, but had little to no effect when supplemented in an Arg-
adequate diet. Fisher et al. (1956), contrary to previous research, reported that Cre 
supplementation elicited very little growth improvement, compared with other diets 
supplemented with Arg, Gly, Met, or their combinations. Savage and O'Dell (1960) reported that 
Cre supplementation improved growth performance of chicks fed Arg-deficient diets, and spared 
about 0.42% Arg. Whereas Cre supplementation can clearly spare Arg, use of Cre in poultry 
diets is impractical due to issues with product stability and cost (Baker (2009). 
Guanidinoacetic Acid 
Guanidinoacetic acid may serve as a better feed additive because it is more stable and 
cost effective than Cre. Almquist et al. (1941) theorized that GAA could spare Arg, along with 
Cre and Crn. This theory was later supported by Edwards Jr. et al. (1958), providing clear 
 
 
16 
 
evidence that GAA was converted to Cre in chicks. These studies also indicated that Arg was 
spared and was used for muscle protein accretion (i.e., body weight gain). Other studies have 
also shown that supplementation of GAA is comparable to Cre supplementation in chicks fed 
Arg deficient diets (Savage and O'Dell, 1960). Michiels et al. (2012) reported that GAA 
supplementation of 0.12% increased the gain:feed ratio when compared with a negative control 
diet, and both 0.06% and 0.12% GAA supplementation improved gain:feed by an average of 
2.3% compared with the negative control. Michiels, et al. (2012) also reported improved beast 
meat yield with GAA supplementation that was comparable to the positive control diet. Mousavi 
et al. (2013) reported that addition of 0.06% GAA improved feed conversion ratio over periods d 
23 to 40 and d 0 to 40 by 4% and 3%, respectively, when compared with a practical Arg-
adequate diet without added GAA. Mousavi et al. (2013) also reported that feed conversion ratio 
was improved with 0.06% GAA supplementation from d 0 to 40 to a nutritionally-complete diet. 
Dilger et al. (2013) reported that there was an improvement in gain:feed ratio when feeding 
0.12% GAA in practical Arg-deficient diets, which was comparable to 0.15% Cre and 0.25% 
Arg supplementation. Murakami, et al.(2014) reported improved weight gain and feed 
conversion in offspring of GAA supplemented breeder quail, indicating that GAA 
supplementation may be advantageous beyond growth. Collectively, results of these reports 
indicate GAA may serve as a commercially-viable compound to improve growth performance of 
broiler chickens by sparing Arg for use in protein synthesis, and GAA supplementation should 
theoretically also positively influence muscle phosphagen concentrations. 
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Conclusion 
 With the increasing use of non-traditional feed ingredients and lower protein poultry 
diets, there is risk of experiencing amino acid deficiencies when using practical diets. Currently, 
crystalline Arg is too expensive to be included in practical diets, yet Arg is the fifth limiting 
amino acid in most poultry diets (Waguespack et al., 2009). Therefore, the following studies 
were conducted to determine the effects of GAA supplementation on growth performance and 
muscle energy metabolites in practical diets for broiler chickens.
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Figures  
 
Figure 2.1 Pathways of arginine synthesis. 1, phosphate-dependent glutaminase (EC 3.5.1.2); 2 and 3, 
P5C synthetase (EC number not assigned); 5, ornithine aminotransferase (OAT; EC 
2.6.1.13); 6, ornithine carbamoyltransferase (OCT; EC 2.1.3.3); 7, argininosuccinate synthase (AS; EC 
6.3.4.5); 8, argininosuccinate lyase (AL; EC 4.3.2.1); 9, N-acetylglutamate synthase (EC 2.3.1.1); 10, 
carbamoyl-phosphate synthase I (ammonia) (CPS I; EC 6.3.4.16); 11, proline oxidase (EC number not 
assigned); 12, aspartate aminotransferase (EC 2.6.1.1). Abbreviations: OAA, oxaloacetate; CP, carbamoyl 
phosphate. Adapted from Wu and Morris (1998). 
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Figure 2.2  Schematic representation of the reactions and enzymes involved in vertebrate creatine and 
creatinine metabolism. The respective enzymes are denoted by numbers: 1, L-arginine:glycine 
amidinotransferase (AGAT; EC 2.1.4.1); 2, S-adenosyl- L-methionine:N-guanidinoacetate 
methyltransferase (GAMT; EC 2.1.1.2); 3, creatine kinase (CK; EC 2.7.3.2); 4, arginase (L-arginine 
amidinohydrolase; EC 3.5.3.1); 5, ornithine carbamoyltransferase (EC 2.1.3.3); 6, argininosuccinate 
synthase (EC 6.3.4.5); 7, argininosuccinate lyase (EC 4.3.2.1); 8, 
L-ornithine:2-oxo-acid aminotransferase (OAT; EC 2.6.1.13); N, nonenzymatic reaction. Adapted from 
Wyss Kaddurah-Daouk (2000).
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Figure 2.3 Biosynthesis of urate. The enzymes involved include: 1, glutamine phosphoribosyl 
pyrophosphate amidotransferase (PRPP amidotransferase); 2, glycineamide ribonucleotide synthetase 
(GAR synthetase); 3, glycineamide ribonucleotide transformylase (GAR transformylase); 4, 
formylglycieamide ribonucleotide amidotransferase (FGAR amidotransferase); 5, aminoimidazole 
ribonucleotide synthetase (AIR synthetase); 6, aminoimidazole ribonucleotide carboxylase (AIR 
carboxylase); 7, N-succinylcarboxamide aminoimidazole ribonucleotide synthetase (SAICAR 
synthetase); 8, adenylosuccinate lyase (adenylosuccinase); 9, aminoimidazole carboxamide ribonucleotide 
transformylase (AICAR transformylase); 10, IMP cyclohydrase (IMP synthetase, inosinicase); 11, 5’-
ribonucleotide phosphohydrolase (5’-nucleotidase); 12, nucleoside phosphohydrolase (nucleoside 
phosphorylase); 13, xanthine: NAD+ oxidoreductase (xanthine dehydrogenase, XDH); 14, 
phosphopentomutase; and 15, ATP:ribose-5-P pyrophosphotransferase (5’phosphoribosyl 
pyrophosphokinase). Adapted from Campbell (1995). 
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Figure 2.4. Pathway of creatine metabolism. 1, L-arginine:glycine amidinotransferase (AGAT) 2, S-
adenosyl- L-methionine:N-guanidinoacetate methyltransferase (GAMT) 3, creatine kinase (CK) 4, 
spontaneous. Adapted from Persky and Brazeau (2001).
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Figure 2.5 Phosphocreatine “shuttle” system. Adapted from Guimaraes-Ferreira (2014). 
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Chapter 3  
 
EFFICACY OF GUANIDINOACETIC ACID ON GROWTH AND MUSCLE 
PHOSPHAGENS WHEN INCLUDED IN ARGININE-DEFICIENT DIETS 
 
 
Abstract 
 Guanidinoacetic acid is formed from Arg and is the immediate precursor to creatine 
(Cre). A study was conducted to determine the ability for GAA to spare Arg in broiler chicks fed 
an Arg-deficient practical diet. A common basal diet (0.84% digestible Arg) was supplemented 
with combinations of Arg (0 or 0.16%) and GAA (0, 0.06, or 0.12%) to form a 2 × 3 factorial 
arrangement of dietary treatments. Additionally, the basal diet was supplemented with 0.32% 
Arg (1.16% digestible Arg) to serve as a positive control. Diets were fed in mash form to 8 
replicate pens of 5 chicks per treatment from d 8 to 22 post-hatch, with measurements including 
growth performance, blood and tissue metabolite concentrations, and clinical outcomes. 
Supplementation of Arg increased (P < 0.05) BWG from d 15 to 22 post-hatch, with the PC diet 
eliciting greater (P < 0.05) BWG than the NC diet. Supplementation of either Arg or GAA 
increased (P < 0.05) gain:feed ratio (G:F) from d 15 to 22 and d 8 to 22 post-hatch, with NC-fed 
birds exhibiting greater (P < 0.05) G:F than PC-fed birds. An interactive effect (P < 0.05) was 
observed as serum GAA was more responsive to supplementation of GAA compared with Arg. 
Interactive effects (P < 0.05) due to Arg and GAA supplementation were also observed for 
concentrations of muscle total creatine, whole breast creatinine, and nearly every AA in serum, 
and PC-fed birds had greater (P < 0.05) responses for nearly all blood and tissue outcomes 
compared with NC-fed birds. Very few effects were noted for clinical chemistry and 
hematological outcomes from this study. Overall, these observations indicate that GAA 
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supplementation alleviated the growth-depressive effects of an Arg deficiency (i.e., GAA spared 
Arg) and positively affected muscle phosphagen concentrations in broiler chicks fed practical 
diets. 
Introduction 
As prices of commodity crops rise due to poor weather conditions, and with increased 
product demand, producers increasingly look for alternative feed ingredient to use as substitutes. 
These non-traditional feed ingredients can be highly variable, however, resulting in the 
possibility of lower protein and amino acid concentrations compared with traditional ingredients. 
With the increased use of alternative protein sources, along with diets formulated with lower 
crude protein levels, there is a necessity for the inclusion of crystalline amino acids. Arginine is 
considered the fifth limiting amino acid for broiler chickens (Fernandez et al., 1994; Han et al., 
1992; Waguespack et al., 2009), but is not currently commercially available. Combined with 
lower crude protein formulations with alternative ingredients, increased growth rate of modern 
broilers (Havenstein et al., 2003), and a lack of de novo synthesis of Arg (Tamir and Ratner, 
1963a), supplementation of dietary Arg may be needed for optimal growth (Han et al., 1992). 
Without a commercially-available source of Arg, the poultry industry may soon have a need for 
an Arg replacement, and one way to achieve this may be providing a feed additive that can spare 
the use of Arg. 
Guanidinoacetic acid (GAA) is a naturally occurring compound that is either synthesized 
in vivo from Arg and Gly via arginine:glycine amidinotransferase (AGAT) or produced via 
chemical synthesis. After formation or absorption from the small intestine (2009; Ostojic et al., 
2013), GAA is converted into creatine (Cre) via guanidinoacetic methyltransferase (GAMT) and 
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then phosphorylated to phosphocreatine (PCr), which is necessary to maintain energy 
homeostasis in muscle cells (Wyss and Kaddurah-Daouk, 2000). Therefore, GAA may be 
important not only for sparing Arg, but also to help maintain overall energy homeostasis in the 
bird. 
 The Arg-sparing capacity of GAA was previously studied (Edwards Jr. et al., 1958; 
Savage and O'Dell, 1960), but this work was conducted almost exclusively using purified diets. 
More recent research (Dilger et al., 2013) indicates that GAA improves feed efficiency when 
supplemented to Arg-deficient practical diets. Because GAA is the precursor of Cre, the sparing 
effect of GAA may be due to the decreased need for GAA synthesis for Cre production. Based 
on previous evidence that GAA-supplementation of Arg-deficient diets elicited an improved 
growth response, we sought to quantify the dose-response relationship of GAA on growth 
performance and tissue metabolite concentrations when included in practical broiler chicken 
diets containing varying concentrations of Arg.  
Materials and Methods 
 All animal care procedures were approved by the University of Illinois Institutional 
Animal Care and Use Committee before initiation of the studies. 
Animals and Diets 
Two-hundred eighty male Ross 708 chicks (Hoovers Hatchery, Rudd, IA) were 
maintained in thermostatically-controlled starter batteries with raised-wire floors in an 
environmentally-controlled room with continuous lighting. Water and experimental diets were 
provided on an ad libitum basis throughout the 14-d feeding period.  
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Chicks received a diet adequate in all nutrients (NRC, 1994) from d 2 to 7 post-hatch. 
Following an overnight fast, chicks were weighed, wing-banded, and assigned to treatments on d 
8 post-hatch such that the average initial pen weights were not different among all treatments. 
Eight replicate pens of 5 chicks received one of 7 treatment diets during a 14-d study (d 8 to 22 
post-hatch). Chicks and feeders were weighed on d 8, 15, and 22 post-hatch, and body weight 
gain, feed intake, and gain:feed ratio were calculated for each replicate pen of chicks.  
The Arg-deficient basal diet (0.84% digestible Arg) consisted primarily of corn, soybean 
meal, distillers dried grains with solubles (DDGS), and corn gluten meal (Table 3.1). Vitamin 
and mineral premixes, as well as crystalline amino acids, were incorporated into the basal diet to 
meet or exceed requirements for broiler chicks (NRC, 1994), with the exception of Arg (Table 
3.2). A common basal diet was supplemented with 2 levels of Arg (0 or 0.16%) and 3 levels of 
GAA (0, 0.06, or 0.12%) to form a 2 × 3 factorial arrangement of dietary treatments, with the 0% 
Arg and 0% GAA supplemented diet serving as the negative control. Additionally, the basal diet 
was supplemented with 0.32% Arg (1.16% digestible Arg) to serve as a positive control. Study 
diets were fed in mash from in a single feeding phase that lasted from d 8 to 22 post-hatch.  
Sample Collection 
On d 22 post-hatch, one bird per pen was randomly chosen and euthanized via an 
intracardiac injection of 390 mg/ml sodium pentobarbital at 0.2 ml/kg BW to facilitate rapid 
collection of breast muscle tissue. A muscle biopsy sample, ranging from 1 to 5 g of wet tissue, 
was collected within 30 s of euthanasia and immediately immersed directly in liquid nitrogen 
until gas elaboration ceased (up to 60 s). Time from euthanasia to flash-freezing of the muscle 
biopsy was no more than 60 s for any individual bird. Snap-frozen muscle biopsy samples were 
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then shattered using blunt force, with frozen muscle aliquots randomly dispensed into pre-cooled 
cryovials and placed back in liquid nitrogen until transferred to storage at -80°C. At no point 
were flash-frozen muscle biopsy samples allowed to thaw. Following rapid muscle biopsy 
collection, the remainder of each breast muscle was excised and stored on ice in a sealed bag 
prior to storage at -20°C. 
Only upon successful muscle collection were remaining birds in each pen euthanized by 
CO2 asphyxiation. A pooled blood sample from 2 of the remaining birds per pen was collected 
from the heart into evacuated tubes containing either EDTA, heparin, or no additive to preserve 
whole blood, serum, and plasma samples, respectively. Samples for plasma were stored on ice 
and serum was allowed to clot at room temperature for no more than 2 h before samples were 
processed and stored. Serum and plasma samples were separated by centrifugation at 1,300 x g at 
20°C and 4°C, respectively, and allocated into separate tubes and stored at -80°C.  
Chemical Analyses 
Muscle PCr, free Cre, and ATP concentrations were quantified (Harlan Laboratories, 
Itingen, Switzerland) using fully-validated procedures. In brief, muscle biopsy samples were 
freeze-dried, powdered, and following extraction of the powder with perchloric acid (PCA), an 
aliquot of 25 µL of neutralized PCA extract (corresponding to 250 µg of dried muscle) was used 
for the simultaneous determination of ATP and PCr. For determination of Cre, the neutralized 
extract was diluted 1:5 with assay buffer, and in a single run, undiluted extract was used for the 
analysis of Cre. The analytical method was based on enzymatic determinations, which ultimately 
resulted in either reduction of NADP to NADPH (ATP, PCr) or oxidation of NADH to NAD 
(Cre), measured spectrophotometrically at 340 nm in perchloric acid-extracted, dried tissue 
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samples. Linearity, accuracy, precision, and selectivity of these assays were tested and achieved 
prior to analysis of test muscle biopsy samples. Final data included the absolute concentration of 
each Cre-related metabolite (ATP, PCr, and Cre), along with calculation of absolute 
concentration of total Cre (tCre; PCr plus free Cre) and relative proportions (PCr:ATP and 
PCr:total Cre). 
Whole breast samples were analyzed (AlzChem AG, Trostberg, Germany) for GAA, total 
Cre, Crn, and homocysteine concentrations using fully-validated procedures (data not shown). 
Serum and plasma were analyzed for amino acids, Cre, Crn, GAA, and homocysteine using 
standardized procedures (Baylor University, Huston, TX). Whole blood was submitted to the 
University of Illinois Urbana-Champaign Veterinary Diagnostic Laboratory for analysis of 
hematological and clinical pathology parameters. Blood biochemistry was assayed using an 
automated spectrophotometric method on a Hitachi 917 analyzer (Roche, Indianapolis, IN), 
while hematological parameters were assessed using a combination of automated and manual 
procedures. 
Statistical Analysis 
 Data were analyzed as a 2-way ANOVA using the GLM procedure of SAS (SAS Inst., 
Cary, NC). Dietary supplemental Arg and GAA concentrations were independent variables in 
this model. When interactive effects were noted, means separation was conducted using a 
Tukey’s adjustment. Additionally, a two-tailed Dunnett’s test was used to compare the positive 
control with all other treatments. Overall treatment effects with a probability of P < 0.05 were 
accepted as statistically significant. 
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Results 
 Overall, formulation objectives were achieved in terms of creating an Arg-deficient basal 
diet, and graded supplementation of Arg and GAA was realized in the final diets (Table 3.2). 
Growth Performance 
 Body weight gain d 15 to 22 and d 8 to 22 post-hatch increased (P < 0.05) due to Arg 
supplementation, with the negative control (NC; 0% supplemental Arg and GAA) diet exhibiting 
reduced (P < 0.05) BWG compared with the PC (Table 3.3). Gain:feed ratio (G:F) increased (P 
< 0.05) with increasing dietary Arg or dietary GAA supplementation during d 15-22 and d 0-22 
post-hatch.  
Tissue Analysis 
Muscle PCr concentrations independently increased (P < 0.05) due to dietary addition of 
either Arg or GAA (Table 3.4). Supplementation of the basal diet with 0.16% Arg and 0.12% 
GAA increased (P < 0.05) PCr concentrations by 46% compared with the PC diet. The ratio of 
PCr:ATP also independently increased (P < 0.05) due to dietary addition of either Arg or GAA. 
Supplementation of the basal diet with 0.16% Arg and 0.12% GAA resulted in PCr:ATP ratio 
that was increased (P < 0.05) 72% over that of the PC diet. Graded GAA supplementation 
increased muscle tCre concentrations, but the effect was more pronounced in diets containing 
added Arg (interaction, P < 0.05). The addition of 0.16% Arg and 0.12% GAA resulted in tCre 
levels that were increased (P < 0.05) 26% compared with the PC diet. The ratio of PCr:tCre 
increased independently ( P < 0.05) due to dietary addition of GAA. Muscle GAA was measured 
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but not reported due to most samples containing GAA concentrations below the detection limit 
(<5 mg/kg). 
Blood Analysis  
 Serum Arg concentrations were unchanged by graded GAA in diets containing 0% added 
Arg, but increased 38% due to addition of 0.12% GAA in diets containing 0.16% added Arg 
(interaction, P < 0.05; Table 3.5). Interactive effects (P < 0.05) were also observed for His, Ile, 
Lys, Phe, and Val, which decreased an average of 34 and 7% due to addition of 0.12% GAA 
when included in diets containing 0.0 or 0.16% added Arg, respectively. Glutamine was the only 
non-essential AA that exhibited an interaction (P < 0.05), with all other non-essential AA (except 
Asn) decreasing (P < 0.05) due to Arg supplementation. Additionally, Ala decreased (P < 0.05) 
due to graded addition of GAA, regardless of dietary Arg concentration.  
Graded GAA supplementation increased serum GAA concentrations, but the effect was 
more pronounced in diets containing added Arg (interaction, P < 0.05). Moreover, addition of 
either 0.06 or 0.12% GAA increased (P < 0.05) serum GAA by at least 323% when compared 
with the PC diet. Serum Cre concentrations independently increased (P < 0.05) due to dietary 
addition of either Arg or GAA. Blood Crn was measured, but not reported, due to all samples 
containing Crn levels below detection limits (< 83 µM). Serum concentrations of citrulline, 
phosphoserine, and phosphoethanolamine increased due to GAA addition to Arg-
unsupplemented diets, but were unchanged when GAA was added to diets containing 
supplemental Arg (interaction, P < 0.05). Opposite interactive effects (P < 0.05) were observed 
for alpha-aminobutyric acid and 3-methylhistidine, which decreased due to GAA addition to 
Arg-unsupplemented diets, but were unchanged when GAA was added to diets containing 
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supplemental Arg. Serum ornithine increased (P < 0.05) 117% due to Arg supplementation, and 
a main effect (P < 0.05) of GAA supplementation was observed for taurine. Finally, serum 1-
methylhistidine decreased (P < 0.05) by 18 and 27% due to supplementation with either 0.16% 
Arg or 0.12% GAA, respectively.  
Clinical chemistry and hematological outcomes were also affected by dietary treatments 
(Table 3.6). An interaction (P < 0.05) was observed for glucose, with 0.12% added GAA 
increasing glucose concentrations by 2.7% in Arg-unsupplemented diets and decreasing glucose 
concentrations by 4.1% in Arg-supplemented diets. Plasma phosphorus concentrations and Glu 
dehydrogenase activity were both decreased (P < 0.05) due to Arg supplementation, and Glu 
dehydrogenase activity was also decreased (P < 0.05) due to GAA supplementation. In terms of 
hematological responses, blood protein concentrations decreased (P < 0.05) due to 
supplementation of either Arg or GAA (Table 3.7). As a proportion of total blood leukocytes, 
heterophils decreased (P < 0.05), while lymphocytes increased (P < 0.05), due to graded GAA 
supplementation.  
Discussion 
The study was designed to test the efficacy of GAA for supporting growth and restoring 
muscle phosphagen status in fast-growing broiler chicks fed an Arg-deficient diet based on 
practical ingredients. Combined with a general lack of effects on hematological and clinical 
chemistry outcomes, this research provides clear and direct evidence of GAA efficacy in 
practical Arg-deficient diets fed to broiler chicks. 
The improvement in growth performance indicates that we effectively created an Arg 
deficiency in the chicks, but were also able to alleviate that deficiency with increased Arg 
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supplementation. Improvements in growth performance when GAA was added to Arg-deficient 
diets are in agreement with previous research conducted by Savage and O’Dell (1960) and Dilger 
et al. (2013). Although there was no BWG response due to GAA supplementation, this was also 
in agreement with previous research (Dilger et al., 2013). Improvements in FCR likely occurred 
because Arg was spared from serving as a precursor for Cre synthesis (Almquist et al., 1941) and 
was therefore available for alternative functions throughout the body; a theory that is in 
agreement with the research conducted by Edwards et al. (1958). In general, GAA was able to 
improve, and in some instances restore, growth performance of birds receiving Arg-deficient 
diets containing practical ingredients common to the U.S. poultry industry. 
In our study, dietary Arg deficiency decreased concentrations of muscle PCr compared 
with the PC diet. Because PCr is used to maintain muscle energy homeostasis (Walker, 1979), 
the decrease in PCr means that muscles in Arg-deficient birds were less able to maintain energy 
homeostasis, and therefore may have reduced muscle performance. Regardless of Arg 
supplementation, GAA increased PCr such that they were never different from the PC. This 
indicates that GAA improves energy homeostasis in muscles cells when supplemented in an Arg-
deficient diet. Relative to the NC diet, tCre concentrations were increased due to 0.12% GAA 
supplementation by 64% and 59% in diets containing 0.84% and 1.00% Arg, respectively. These 
results corroborate recent observations by Michiels et al. (2012), who reported that Cre 
concentrations in breast meat increased by 16% due to supplementation of 0.12% GAA in an 
Arg-adequate diet. Because the maintenance of PCr is based on Cre being phosphorylated to PCr 
and exported to sites of ATP usage (Brosnan and Brosnan, 2010; Guimarães-Ferreira, 2014), the 
increased tCre concentration may indicate the increased capacity for PCr due to increased overall 
Cre concentrations. Also, both the absolute concentration and relative ratio (to ATP) of PCr and 
 
 
38 
 
tCre were improved with GAA supplementation, indicating in both cases that GAA 
supplementation may increase the ability of cells to regenerate ATP more effectively. Because of 
the increase in muscle metabolite concentrations, we can conclude that dietary GAA is 
successfully absorbed and metabolized to synthesize Cre with efficacy greater than dietary Arg, 
which indicates that GAA supplementation spares dietary Arg (Wyss and Kaddurah-Daouk, 
2000). 
Supplementation of GAA reduced plasma AA concentrations in birds, with more drastic 
decreases observed in diets containing 0.84% digestible Arg. This indicates that as the Arg 
deficiency was alleviated, essential AA concentrations in plasma decreased. Zimmerman and 
Scott (1965) reported a similar trend in BWG and plasma AA concentrations as dietary lysine 
approached the requirement. The improvement in BWG and decrease in plasma AA can be 
explained in the context of the ideal protein concept, which is based on the premise that optimal 
performance is limited by availability of the scarcest resource. In these diets, Arg is the most-
limiting amino acid, and as the body has no AA storage, any excess AA remaining after attaining 
maximal growth are transported via the blood to the liver for deamination and subsequent 
oxidation to generate ATP. Therefore, GAA added to diets containing either 0.84 or 1.00% Arg 
may spare Arg by diminishing the need for Arg to serve as a precursor for Cre synthesis, 
therefore making more Arg available for incorporation into lean tissue along with excess AA and 
decreasing blood AA concentrations. 
In addition to decreased growth in general, evidence from blood chemistry and 
hematological outcomes indicate that protein degradation may have occurred in Arg-deficient 
birds. Blood 3-methylhistidine decreased with dietary supplementation of GAA to Arg-
unsupplemented diets, but were unchanged when GAA was supplemented to containing 
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supplemented Arg. Supplementation of GAA also decreased heterophils as the largest proportion 
of total leukocytes, while dietary Arg concentration had no effect. Heterophil proportions were 
reduced with GAA supplementation an average of 35% when birds were supplemented with 
0.12% GAA compared with 0.0% GAA. There was also a reciprocal change in lymphocyte 
percentages, the normal circulating leukocyte (Weiss et al., 2010), as heterophil percentage 
decreased. The combination of decreased 3-methylhistidine concentrations and heterophil 
percentages in birds with increased GAA supplementation indicates that Arg deficiency may 
cause minor changes in whole-body protein degradation. Although 3-methylhistidine is an 
indication of skeletal protein degradation (Young and Munro, 1978), it is typically related to 
body weight loss. However, when combined with the high proportion of white blood cells as 
heterophils, a sign of muscle damage (Weiss, et al., 2010), there may be some protein 
degradation that occurs in Arg-deficient birds. Therefore, GAA supplementation may reduce 
metabolic stress (i.e., protein degradation) caused by dietary Arg deficiency. 
The alleviation of an Arg deficiency is associated with changes in Arg-related 
metabolites. Blood ornithine (Orn) concentrations were increased with graded Arg 
supplementation, but GAA supplementation had no effect. The production of Orn may increase 
with Arg supplementation due to the increased production of urea by avian arginase (Fernandes 
and Murakami, 2010; Tamir and Ratner, 1963a); this could be quantified further if blood urea 
had been measured. Increased blood Orn concentrations may also indicate that more GAA and 
Orn are formed from Arg and Gly due to Arg supplementation (Walker, 1979). Supplementation 
of GAA decreased Orn concentrations by at least 33% and 12% in the 0.84% Arg diet and 1.00% 
Arg diet with 0.0% GAA, respectively. This was expected because the supplementation of GAA 
spares dietary Arg most in Arg deficient diets. Blood citrulline (Cit) levels were increased with 
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the supplementation of GAA, although to a much lower effect when dietary Arg was closer to 
adequate concentrations. This could be due to increased nitric oxide production, which also 
produces Cit (Wu and Morris Jr., 1998), but also a decreased conversion of Cit to Arg (Tamir 
and Ratner, 1963b) in chicks with a decreased deficiency. Serum Cit concentrations increased 
dramatically with GAA supplementation in Arg-unsupplemented diets, indicating that Cit levels 
may be a way to measure Arg deficiency and that GAA effectively reduced the deficiency by 
sparing Arg in unsupplemented diets. 
Overall, it can be concluded from this study that dietary GAA may spare Arg when Arg-
deficient diets are fed to young broiler chicks. Our results indicate that 0.12% supplemental 
GAA was capable of ameliorating the effects of an Arg deficiency on growth performance and 
muscle phosphagen concentrations caused by a dietary Arg deficiency, with outcomes due to this 
treatment closely matching responses of chicks fed an Arg-adequate diet. While Arg-sparing 
effects of GAA were evident in Arg-deficient diets based on practical ingredients, further studies 
are warranted to determine whether GAA can also improve outcomes in chicks consuming an 
Arg-adequate diet. 
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Tables 
Table 3.1. Basal diet formulation and nutrient composition 
Ingredient, % Value 
Corn 57.57 
Soybean Meal 10.03 
DDGS 12.04 
Corn Gluten Meal 11.54 
Soy Oil 3.01 
Salt 0.40 
Limestone 1.50 
Dicalcium Phosphate 1.71 
Vitamin Premix1 0.20 
Mineral Premix2 0.15 
Choline Chloride 0.20 
Titanium Dioxide 0.40 
L-Lysine HCl 0.70 
DL-Methionine 0.25 
L-Isoleucine 0.06 
L-Threonine 0.18 
L-Tryptophan 0.05 
  
Calculated Proximates  
 Crude Protein, % 21.3 
 Calcium, % 10.0 
 Phosphorus (total), % 6.8 
 Phosphorus (available), % 4.5 
 AMEN, kcal/kg 3,148 
  
 Calculated  
Amino Acids, % Total Digestible3 Analyzed 
 Arg 9.6 8.4 9.9 
 Ile 8.6 7.6 8.4 
 Leu 25.3 23.1 24.1 
 Lys 12.4 11.4 11.9 
 Met 6.8 6.4 6.2 
 Met+Cys 10.4 9.2 9.9 
 Thr 8.7 7.3 8.6 
 Trp 2.3 1.9 - 
 Val 10.0 8.6 9.3 
1Provided per kg of diet: retinyl acetate, 4,400 IU; cholecalciferol, 25 g; DL-ɑ- tocopheryl 
acetate, 11 IU; vitamin B12, 0.01 mg; riboflavin, 4.41 mg; D-Ca-pantothenate, 10 mg; niacin, 
22 mg; menadione sodium bisulfite, 2.33 mg. 
2 Provided as milligrams per kg of diet: Mn, 75 from MnO; Fe, 75 from FeSO4 • 7H2O; Zn, 75 
from ZnO; Cu, 5 from CuSO4 • 5H2O; I, 0.75 from ethylene diamine dihydroiodide; Se, 0.1 
from Na2SeO3. 
3Acquired from AMINODat® 4.0 (Evonik Industries AG, Hanau-Wolfgang, Germany). 
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Table 3.2. Analyzed composition of negative and positive control treatments1 
Nutrient  Negative Control (NC) Positive Control (PC) 
Crude Protein, % 21.36 22.96 
Crude Fat, % 5.78 5.87 
Crude Fiber, % 2.33 2.20 
Ash, % 6.00 6.53 
   
GAA, mg/kg2 < 1.0 < 1.0 
Creatine, mg/kg2 < 1.0 < 1.0 
Folic Acid, mg/kg 0.94 0.92 
Choline, mg/kg 1,030 1,070 
Betaine, mg/kg 6,800 7,200 
   
Amino Acids, %   
Essential   
 Arg 1.01 1.31 
 His 0.52 0.52 
 Ile 0.86 0.86 
 Leu 2.49 2.49 
 Lys 1.21 1.22 
 Met 0.68 0.66 
 Phe 1.10 1.1 
 Thr 0.87 0.89 
 Val 0.96 0.96 
Non-Essential   
 Ala 1.45 1.43 
 Asp 1.55 1.56 
 Cys 0.38 0.38 
 Glu 3.87 3.87 
 Gly 0.76 0.76 
 Pro 1.57 1.56 
 Ser 1.02 1.01 
1The basal diet was formulated to contain 0.96% total Arg (0.84% digestible Arg) and was 
analyzed to contain 0.99% Arg. 
2Analyzed values were below the stated detection limit. 
3Amino acids values were standardized to a dry matter content of 88%. 
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Table 3.3. Growth performance of chicks fed Arg-deficient diets1 
 Dietary Treatment2
 Suppl. Arg, % 0.00 0.00 0.00 0.16 0.16 0.16 0.32 P-values6
Variable GAA, % 0.003 0.06 0.12 0.00 0.06 0.12 0.004 SEM5 Arg GAA Arg×GAA 
Body weight, g             
 d8 99.3 99.4 99.4 99.3 99.5 99.5 99.3 2.83 1.000 0.998 1.000 
 d15 299.8 285.4 286.3 293.6 299.7 300.4 301.1 10.02 0.626 0.901 0.507 
 d22 627.9 626.2 641.0 642.0 656.3 662.2 668.5 16.37 0.076 0.593 0.888 
BW gain, g/chick            
 d 8-15 200.5 186.0 186.9 194.3 200.2 200.9 201.8 7.52 0.444 0.831 0.305 
 d 15-22 328.1* 340.9 354.7 348.4 356.6 361.8 367.4 8.99 0.008 0.094 0.759 
 d 8-22 528.6 526.8 541.6 542.7 556.8 562.7 569.2 14.39 0.037 0.515 0.857 
Feed intake, g/chick            
 d 8-15 301.4 278.9 278.6 282.1 295.1 283.1 286.9 9.37 0.851 0.466 0.130 
 d 15-22 514.0 516.3 512.4 509.4 518.7 503.3 523.6 13.60 0.771 0.747 0.902 
 d 8-22 815.6 797.7 791.0 791.5 813.8 791.3 810.8 20.98 0.975 0.725 0.590 
Gain:feed, g/kg            
 d 8-15 663.8 666.8 668.9 687.0 680.9 711.4 697.4 17.94 0.100 0.566 0.691 
 d 15-22 637.9* 661.4 693.0 683.9 690.5 718.1 701.9 15.43 0.003 0.011 0.746 
 d 8-22 647.3* 661.5 684.3 685.1 686.9 710.9 700.5 13.63 0.004 0.047 0.865 
*Mean value for this treatment was different from the PC diet (P < 0.05).
1Values are means of 8 replicate pens of 5 chicks during the feeding period 8 to 22 d post-hatch. Arg = arginine, BW = body weight, 
GAA = guanidinoacetic acid.  
2The basal diet was formulated to contain 0.96% total Arg (0.84% digestible Arg) and was analyzed to contain 0.99% Arg. 
3Negative control treatment. 
4Positive control treatment. 
5Standard error of the mean that applies to all 7 dietary treatments. 
6P-values apply only to the first 6 treatments that were included in the 2-way ANOVA. 
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Table 3.4. Muscle analyses of creatine-related metabolites of chicks fed Arg-deficient diets1 
 Dietary Treatment2     
Suppl. Arg, % 0.00 0.00 0.00 0.16 0.16 0.16 0.32   P-values6
Variable      GAA, % 0.003 0.06 0.12 0.00 0.06 0.12 0.004  SEM5 Arg GAA Arg×GAA 
PCr, mmol/kg DW 37.6* 56.1 91.0 61.7 82.4 108.7* 74.4  8.14 0.001 < 0.001 0.859 
ATP, mmol/kg DW 37.8 38.0 41.0 38.1 40.8 34.1 40.1  2.36 0.617 0.709 0.111 
PCr:ATP 0.99* 1.54 2.20 1.68 2.04 3.24* 1.88  0.24 0.001 < 0.001 0.515 
Free Cre, mmol/kg DW 68.9 56.3 59.5 54.7 76.5 67.3 64.7  7.81 0.741 0.837 0.094 
Total Cre, mmol/kg7 106.6a* 112.4a* 150.6b 116.5a 158.9b 176.0b* 139.2  7.13 < 0.001 < 0.001 0.044 
PCr/total Cre, % 34.5 51.0 60.5 52.2 51.9 61.7 53.7  5.40 0.105 0.007 0.216 
*Mean value for this treatment was different from the PC diet (P < 0.05). 
1ATP = adenosine triphosphate, Cre = creatine, Crn = creatinine, DW = dry weight, GAA = guanidinoacetic acid, PCr = phosphocreatine, WW = wet 
weight. 
2The basal diet was formulated to contain 0.96% total Arg (0.84% digestible Arg) and was analyzed to contain 0.99% Arg. 
3Negative control treatment. 
4Positive control treatment. 
5Standard error of the mean that applies to all 7 dietary treatments. 
6P-values apply only to the first 6 treatments that were included in the 2-way ANOVA. 
7Calculated as PCr plus free Cr. 
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Table 3.5. Blood amino acid and metabolite concentrations (M) of chicks fed Arg-deficient diets 
 Dietary Treatment1
Suppl. Arg, % 0.00 0.00 0.00 0.16 0.16 0.16 0.32   P-values5 
Variable     GAA, % 0.002 0.06 0.12 0.00 0.06 0.12 0.003  SEM4 Arg GAA Arg x GAA 
Essential   
 Arginine 155.8ab* 136.9a* 143.8a* 199.1bc* 244.6cd* 274.0d* 364.9 15.35 < 0.001 0.132 0.019
 Histidine 127.0c* 109.1bc 79.6ab 80.9ab 74.1ab 73.4a 84.7 8.03 < 0.001 0.005 0.046
 Isoleucine 118.4b* 89.4a 82.9a 79.6a 82.9a 76.8a 77.3 4.26 < 0.001 0.001 0.001
 Leucine 434.3* 354.4 334.5 370.3 337.4 318.4 341.1 16.92 0.002 0.001 0.279
 Lysine 579.0c* 470.6bc* 272.5a 297.3ab 237.8a 262.5a 274.3 43.58 < 0.001 0.001 0.007
 Methionine 196.4 181.3 179.6 177.0 158.8 162.0 161.6 10.64 0.017 0.219 0.973
 Phenylalanine 217.5 184.1 184.4 188.3 198.8 186.1 172.9 8.67 0.021 0.130 0.042
 Threonine 2,093* 1,839* 1,333 1,410 1,243 1,175 1,254 113.18 < 0.001 0.001 0.054
 Valine 245.1b* 173.3a 160.9a 164.3a 158.3a 148.6a 150.8 8.33 < 0.001 < 0.001 0.001
Non-Essential   
 Alanine 1,328* 1,148 1,077 1,055 991.1 950.1 927.3 71.08 0.001 0.047 0.559
 Asparagine 20.9 43.5 60.3 41.8 59.6 35.0 44.6 21.79 0.862 0.618 0.512
 Aspartic acid 221.9* 220.6* 185.6 176.1 162.6 179.1 157.1 13.32 0.001 0.463 0.141
 Cysteine 85.6* 80.9 75.1 75.0 75.8 72.5 72.9 3.34 0.021 0.149 0.478
 Glutamine 1,243b 1,514c* 1,180b 1,095ab 1,070ab 882.6a* 1,095 54.66 < 0.001 < 0.001 0.033
 Glutamic acid 266.0* 250.5 254.4 224.9 229.9 254.4 224.5 9.43 0.009 0.323 0.103
 Glycine 731.3* 696.3* 632.0* 520.5 521.8 517.0 476  38.27 < 0.001 0.399 0.456 
 Proline 832.8 883.9 886.4 756.3 748.0 745.3 768.5 52.37 0.027 0.895 0.792
 Serine 936.5* 918.0* 800.0 721.9 680.5 652.3 715.0 48.08 < 0.001 0.098 0.628
 Tyrosine 409.6 422.0 365.0 329.9 363.6 337.5 326.9 26.80 0.024 0.308 0.622
Other Metabolites4   
Alpha-aminobutyric 71.9c* 34.8a* 50.5b* 42.5ab* 37.5ab* 36.4ab* 20.4 3.31 < 0.001 < 0.001 < 0.001
Citrulline 2.75a* 9.0b 15.9c* 15.8c* 14.9c* 16.8c* 9.5 1.07 < 0.001 < 0.001 < 0.001
Creatine 14.2* 22.3 37.1 19.8 26.0 43.2* 28.3 3.31 0.006 < 0.001 0.930
Guanidinoacetic acid 0.39d 3.85c* 9.84b* 0.48d 4.91c* 13.95a* 0.91 0.54 < 0.001 < 0.001 0.001
1-methylhistidine 38.1* 30.4 24.6 26.6 27.4 22.8 20.5 2.87 0.001 0.014 0.196
Ornithine 11.0* 7.0* 7.38* 20.1* 17.3* 17.6* 28.0 1.78 < 0.001 0.117 0.936
Phosphoserine 20.6a 19.0a 70.8b* 75.9b* 75.5b* 68.9b* 20.6 3.47 < 0.001 < 0.001 < 0.001
Phosphoethanolamine 2.75ab 2.25a 4.13ab* 14.9c* 4.38b* 4.50b* 1.63 0.48 < 0.001 < 0.001 < 0.001
Taurine 362.9 297.8 340.5 381 288.8 311.8 286.9 29.82 0.074 0.038 0.734
3-methylhistidine 16.3c* 12.6b 7.13a 9.25ab 7.25a 8.88ab 11.0 1.05 0.001 0.001 0.001
a-dMeans within a row lacking a common superscript letter differ (P < 0.05). 
*Mean value for this treatment was different from the PC diet (P < 0.05). 
1The basal diet was formulated to contain 0.96% total Arg (0.84% digestible Arg) and was analyzed to contain 0.99% Arg. 
2Negative control treatment. 
3Positive control treatment. 
4Standard error of the mean that applies to all 7 dietary treatments. 
5P-values apply only to the first 6 treatments that were included in the 2-way ANOVA. 
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Table 3.6. Plasma clinical pathology outcomes of chicks fed Arg-deficient diets 
 Dietary Treatment1    
Suppl. Arg, % 0.00  0.00 0.00 0.16 0.16 0.16 0.32   P-values5 
Variable     GAA, % 0.002 0.06 0.12 0.00 0.06 0.12 0.003  SEM4 Arg GAA Arg x GAA 
Albumin, g/dL 1.10 1.13 1.14 1.1 1.00 1.08 1.05  0.05 0.240 0.559 0.430 
Glucose, mg/dL 232.1ab 244.6b 238.3ab 241.5ab 220.4a 231.5ab 236.8  5.36 0.267 0.725 0.011 
Asp aminotransferase, U/L 136.75 148.25 143.88 135 131.75 146.38 145  7.37 0.417 0.459 0.407 
Phosphorus, mg/dL 7.60 8.39 7.98 7.53 7.20 7.39 7.68  0.27 0.027 0.701 0.136 
Calcium, mg/dL 10.69 10.85 10.68 10.61 10.28 10.85 10.45  0.21 0.501 0.647 0.214 
Glu dehydrogenase, U/L 6.78 4.76 5.40 4.95 3.33 3.69 4.81  0.66 0.007 0.025 0.956 
Creatine kinase, U/L 2,106 1,908 2,586 2,672 2,133 2,379 2,178  303.98 0.622 0.280 0.416 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
*Mean value for this treatment was different from the PC diet (P < 0.05). 
1The basal diet was formulated to contain 0.96% total Arg (0.84% digestible Arg) and was analyzed to contain 0.99% Arg. 
2Negative control treatment. 
3Positive control treatment. 
4Standard error of the mean that applies to all 7 dietary treatments. 
5P-values apply only to the first 6 treatments that were included in the 2-way ANOVA. 
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Table 3.7. Hematology outcomes of chicks fed Arg-deficient diets 
 Dietary Treatment1    
Suppl. Arg, % 0.00  0.00 0.00 0.16 0.16 0.16 0.32   P-Value5 
Variable     GAA, % 0.002 0.06 0.12 0.00 0.06 0.12 0.003  SEM4 Arg GAA Arg x GAA 
Packed cell volume, % 28.7 28.2 29.1 28.3 28.5 28.9 28.5  0.86 0.994 0.682 0.895 
Protein, g/dL 3.36 3.03 3.15 3.18 2.86 2.99 3.03  0.96 0.009 0.003 0.995 
Differential cell counts, 103/L             
 Total leukocytes 10.65 12.88 11.08 9.86 9.99 13.97 9.89  1.95 0.972 0.455 0.270 
 Heterophils 5.14 4.93 3.88 4.88 4.35 4.62 4.33  0.76 0.738 0.549 0.605 
 Lymphocytes 4.57 5.93 5.82 3.75 3.98 7.69 4.34  1.57 0.965 0.190 0.392 
 Monocytes 0.35 0.57 0.30 0.43 0.53 0.80 0.43  0.21 0.488 0.674 0.287 
 Eosinophils 0.25 0.44 0.16 0.21 0.24 0.28 0.18  0.09 0.591 0.325 0.071 
 Basophils 0.48 1.07 0.94 0.74 0.92 0.81 0.67  0.27 0.950 0.246 0.591 
Differential cell proportions, %6             
 Heterophils 61.0 40.0 35.3 51.0 44.0 37.7 44.0  5.63 0.172 0.001 0.330 
 Lymphocytes 28.4 44.5 52.2 35.9 40.9 49.6 43.9  6.37 0.272 0.008 0.571 
 Monocytes 3.67 4.60 2.75 5.13 5.25 5.40 4.71  1.86 0.504 0.878 0.836 
 Eosinophils 2.80 2.50 1.57 2.57 2.29 2.29 2.25  0.67 0.833 0.361 0.598 
 Basophils 5.43 8.00 8.38 6.67 7.88 6.57 6.00  1.73 0.836 0.263 0.568 
Subjective observations7             
 Reactive lymphocytes 1/7 4/6 2/8 3/8 3/8 3/7 2/7      
 Immature erythrocytes - - - - - - 1/7      
 Vacuoles in heterophils - 5/6 - - 6/8 4/7 -      
 Hypogranulated heterophils - 1/6 - - - - -      
 Granulated lymph - 1/6 - - 2/8 1/7 -      
1The basal diet was formulated to contain 0.96% total Arg (0.84% digestible Arg) and was analyzed to contain 0.99% Arg. 
2Negative control treatment. 
3Positive control treatment. 
4Standard error of the mean that applies to all 7 dietary treatments. 
5P-values apply only to the first 6 treatments that were included in the 2-way ANOVA. 
6Differential cell counts expressed as a proportion of total leukocytes detected. 
7Values represent number of positive observations per total number of samples analyzed. 
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Chapter 4 
 
EFFICACY OF GUANIDINOACETIC ACID ON GROWTH AND MUSCLE 
PHOSPHAGENS WHEN INCLUDED IN BOTH ARGININE-DEFICIENT AND 
ARGININE-ADEQUATE DIETS 
 
 
Abstract 
Two studies were conducted to test the Arg-sparing efficacy of GAA in supporting 
growth performance and muscle phosphagen homeostasis in broiler chicks. In both studies, 12 
replicate pens of 6 chicks received dietary treatments beginning at d 2 post-hatch. At conclusion 
of each study, muscle biopsy samples were collected within 60 s of euthanasia for analysis of 
creatine (Cre)-related metabolites. In study 1, Arg-deficient starter and grower basal diets (0.97 
and 0.84% digestible Arg, respectively) were supplemented with 0 (negative control, NC), 0.06, 
0.12, or 0.18% guanidinoacetic acid (GAA), or supplemental Arg (positive control, PC; 0.37% 
and 0.32% L-Arg in starter and grower phases, respectively). Final BW and overall BW gain 
were increased (P < 0.05) by 0.12% GAA compared with the NC diet, and overall gain:feed 
(G:F) was increased (P < 0.05) in the same fashion. Supplementation of 0.12% GAA also 
increased (P < 0.05) phosphocreatine (PCr) and total Cre concentrations, as well as the PCr:ATP 
ratio, compared with the NC diet. In study 2, Arg-adequate starter and grower basal diets (1.32 
and 1.19% digestible Arg, respectively) were supplemented with 0 (negative control, NC), 0.06, 
or 0.12% GAA, 0.12% Cre monohydrate (PC1), or salmon protein (PC2; containing total Arg 
concentrations equal to those of the NC diet in each phase). Overall G:F was increased (P < 
0.05) by PC1 compared with the NC, but GAA supplementation had no effect. However, 0.12% 
GAA increased (P < 0.05) concentrations of PCr and total Cre, as well as the PCr:ATP ratio, 
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relative to the NC (Arg-adequate) diet. Collectively, these data indicate that GAA can be used to 
replace Arg in practical diets containing either deficient or adequate concentrations of Arg when 
fed to broiler chicks. 
Introduction 
As prices of commodity crops rise, the use of feed ingredient substitutes and alternatives 
increase. These alternative feed ingredients may be more variable, however, compared with 
traditional ingredients, resulting in possible reduced protein and amino acid concentrations in 
animal diets. This variability in protein levels, along with a decreasing level of crude protein in 
diet formulation, necessitates the inclusion of crystalline amino acids.  Arginine is the fifth 
limiting amino acid for broiler chickens (Fernandez et al., 1994; Han et al., 1992; Waguespack et 
al., 2009), but is not commercially available. Along with the increased growth rate of modern 
broilers (Havenstein et al., 2003), lack of de novo synthesis of Arg (Tamir and Ratner, 1963), 
and the possibility of reduced protein quality in production diets, supplementation of dietary Arg 
may be needed for optimal growth (Han et al., 1992). Without a commercially-available source 
of Arg, the poultry industry may soon have a need for an Arg replacement, providing a feed 
additive that can spare the use of Arg as a possible solution. 
Guanidinoacetic acid (GAA) was previously studied for its Arg-sparing effects using 
purified diets (Edwards Jr. et al., 1958; Savage and O'Dell, 1960), and it was reported to be 
comparable to Cre supplementation, and recent work further supports the ability for GAA to 
spare Arg when included in diets based on practical ingredients (Dilger et al., 2013). As the 
immediate precursor of Cre, GAA appears to cause feedback inhibition of its synthesizing 
enzyme, arginine:glycine aminotransferase (AGAT) (Guimarães-Ferreira, 2014; Walker, 1979). 
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However, only limited information exists regarding the dose-dependent ability for GAA to spare 
Arg in practical broiler diets, especially in terms of Cre-related metabolites in muscle (i.e., 
phosphagens). In terms of Arg-adequate diets, current research indicates GAA improves growth 
performance (Michiels et al., 2012; Mousavi et al., 2013), but outcomes related to muscle 
phosphagen status are unavailable.  
We hypothesized that GAA supplementation would elicit positive effects on growth 
performance when included in Arg-deficient, practical broiler diets, with additional benefits 
involving muscle phosphagens concentrations in birds receiving both Arg-deficient and Arg-
adequate diets. Two studies involving dose-dependent effects of GAA were conducted to test 
these hypotheses using broiler chicks.  
Materials and Methods 
 All animal care procedures were approved by the University of Illinois Institutional 
Animal Care and Use Committee before initiation of the studies. 
Animals and Husbandry  
Three-hundred sixty male Ross 708 chicks (Hoovers Hatchery, Rudd, IA) were 
maintained in thermostatically-controlled batteries with raised-wire floors in an environmentally-
controlled room with continuous lighting. Water and experimental diets were provided on an ad 
libitum basis throughout the feeding period. Chicks were weighed, wing-banded, and assigned to 
treatments such that the average initial pen weights were not different among all treatments. 
Study diets were fed in mash form in two feeding phases, starter (d 0 to 14) and grower (d 14 to 
28 post-hatch, study 1; d 14 to 27 post-hatch, study 2), beginning at 2 d post-hatch. On study d 
14, birds were moved from starter (0.06 m2/bird) to grower (0.09 m2/bird) battery pens. Twelve 
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replicate pens of 6 chicks received each of the 5 study diets in each study. To determine BWG, 
FI, and gain:feed ratio, chicks and feeders were weighed on d 0, 14, and 28 of study 1, and on d 
0, 14, and 27 of study 2. In both studies, birds were selected for collection of muscle biopsy 
samples within 24 h after final BW measurements were recorded according to procedures 
described below. All birds not selected for muscle biopsy collection were humanely euthanized 
via CO2 asphyxiation. 
Dietary Treatments 
Study 1. An Arg-deficient basal diet was formulated to meet or exceed requirements for 
broiler chicks (1994), with the exception of Arg (Table 4.1). Dietary treatments included a 
common Arg-deficient basal diet (1.08 and 0.95% total Arg in starter and grower phases, 
respectively) supplemented with 0.0 (negative control, NC), 0.06, 0.12, or 0.18% GAA, or L-Arg 
(positive control, PC; 0.37 and 0.32% L-Arg in starter and grower phases, respectively).  
Study 2. An Arg-adequate basal diet was formulated to meet or exceed requirements for 
broiler chicks for all nutrients (1994) (Table 4.1). Dietary treatments included a common Arg-
adequate basal diet (1.42 and 1.28% total Arg in starter and grower phases, respectively) 
supplemented with 0 (negative control, NC), 0.06, or 0.12% GAA, 0.12% Cre monohydrate 
(PC1), or salmon protein (PC2). The salmon protein-containing diet was formulated to provide 
total Arg concentrations equal to those of the NC diet in each phase of this study. Additionally, 
the PC1 and PC2 were designed to provide the same amount of digestible Cre. 
 
 
 
 
54 
 
Muscle Biopsy Collection 
 Two birds per pen with BW closest to the pen average were identified for muscle 
collection. An attempt was made to use the bird with a BW closest to the pen average for muscle 
sampling. If that bird displayed more than minimal movement prior to samplings, an alternate 
bird with a BW next closest to the pen average was used. In total, a muscle sample from only 1 
bird per pen was collected and analyzed. 
To begin the procedure, a selected bird was injected intramuscularly (on the contralateral 
side of the psoas major where biopsy was to occur) with 2 mg/kg xylazine and 10 mg/kg 
ketamine (Maiti et al., 2006) to reduce the incidence of flapping prior to muscle collection. Birds 
remained calm (i.e., no handling or disruption) in this anesthetized state for 8-12 min before 
muscle biopsies were collected to ensure that muscle phosphagen status was normalized prior to 
sampling; times required for anesthetization are based on preliminary data from our lab (data not 
shown). Constant monitoring was provided by a single observer for all birds during both studies, 
and included time of anesthetic administration and bird condition (e.g., sedated, alert, relaxed, 
flapping, or dead) recorded every 2 min. No birds died as a result of anesthesia prior to 
euthanasia, and alternate birds were selected if the initial bird exhibited one or more bouts of 
movement during the anesthesia period. 
Following the anesthetic period, birds were euthanized via an intracardiac injection of 
390 mg/ml sodium pentobarbital at 0.2 ml/kg BW to facilitate rapid collection of breast muscle 
tissue. A muscle biopsy sample, ranging from 1-5 g of wet tissue, was collected within 30 s of 
euthanasia and immediately immersed directly in liquid nitrogen until gas elaboration ceased (up 
to 60 s). Time from euthanasia to flash-freezing of the muscle biopsy was no more than 60 s for 
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any individual bird. Snap-frozen muscle biopsy samples were then shattered using blunt force, 
with frozen muscle aliquots randomly dispensed into pre-cooled cryovials and placed back in 
liquid nitrogen until transferred to storage at -80°C. At no point were flash-frozen muscle biopsy 
samples allowed to thaw.  
Analysis of Cre-related Metabolites in Muscle 
Muscle phosphocreatine (PCr), free creatine (Cre), and ATP were measured 
simultaneously by an external laboratory (Harlan Laboratories, Itingen, Switzerland) using fully-
validated procedures. In brief, muscle biopsy samples were freeze-dried, powdered, and 
following extraction of the powder with perchloric acid (PCA), an aliquot of 25 µL of 
neutralized PCA extract (corresponding to 250 µg of dried muscle) was used for the 
simultaneous determination of ATP and PCr. For determination of Cre, the neutralized extract 
was diluted 1:5 with assay buffer, and in a single run, undiluted extract was used for the analysis 
of Cre. The analytical method was based on enzymatic determinations, which ultimately resulted 
in either reduction of NADP to NADPH (ATP, PCr) or oxidation of NADH to NAD (Cre), 
measured spectrophotometrically at 340 nm in perchloric acid-extracted, dried tissue samples. 
Linearity, accuracy, precision, and selectivity of these assays were tested and achieved prior to 
analysis of test muscle biopsy samples. Final data included the absolute concentration of each 
Cre-related metabolite (ATP, PCr, and Cre), along with calculation of absolute concentration of 
total Cre (tCre; PCr plus free Cre) and relative proportions (PCr:ATP and PCr:total Cre). 
Statistical Analysis.  
All data were analyzed as a RCBD by a 1-way ANOVA using the Mixed procedure of 
SAS (SAS Inst., Cary, NC). Diet and replicate were independent variables in this model, and pen 
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served as the experimental unit for all response variables. Treatments were compared using 
means separations procedures using least squares means. Overall treatment effects with a 
probability of P < 0.05 were accepted as statistically significant. 
Results 
 In general, all formulation objectives were achieved (Table 4.2). 
Study 1 
 Growth Performance: The PC diet increased (P < 0.05) final BW by 10% and daily 
BWG d 14-28 and d 0-28 by 11 and 10%, respectively, compared with the NC diet (Table 4.3). 
Supplementation with 0.12% GAA increased (P < 0.05) both final BW and daily BWG (d 0-28) 
by 6% compared with the NC diet. In each case, responses to 0.12% GAA supplementation were 
statistically equivalent to the PC diet. Comparatively, supplementation with 0.06% or 0.18% 
GAA only improved BW numerically, with no significant differences evident compared with 
either the NC or PC diets. There were no significant effects of dietary supplementation on feed 
intake during any period in this study. 
Mortality-corrected gain:feed ratio (G:F) was increased (P < 0.05) by 10% on average in 
birds fed the PC diet, compared with the NC diet, during each feeding phase and over the entire 
28-d feeding period. Moreover, G:F was increased (P < 0.05) with increasing concentrations of 
GAA during both the starter (6, 11, and 8%, respectively) and finisher (3, 6, and 7%, 
respectively) periods, with equivalent effects noted when comparing the 0.12% GAA-
supplemented diet with the PC diet during each feeding period. Overall, only diets supplemented 
with GAA at 0.12% or 0.18% improved (P < 0.05) G:F compared with the NC diet during the 
entire 28-d feeding period. 
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Tissue Analysis. Supplementation of either 0.12 or 0.18% GAA increased (P < 0.05) PCr 
concentrations by 66 and 105%, respectively, when compared with the NC diet (Table 4.4). 
Supplementation of 0.12 or 0.18% GAA also increased (P < 0.05) the PCr:ATP ratio by 77 and 
108%, respectively, when compared with the NC diet. Total Cre increased (P < 0.05) by 16, 49, 
and 76% with 0.06, 0.12, or 0.18% GAA supplementation, respectively, compared with the NC 
diet. Supplementation of GAA at 0.12% elicited a tCre concentration that was equal to the PC 
diet, and addition of 0.18% GAA caused tCre to be 11% greater (P < 0.05) than tCre 
concentrations elicited by the PC diet. There were no differences between treatments for absolute 
concentrations of ATP or relative proportions of PCr:tCre. 
Study 2 
 Growth Performance: Body weight gain of chicks receiving Arg-adequate diets did not 
respond to the supplementation of GAA or Cre, with no significant differences study d 0-14 or d 
0-27 (Table 4.5). During d 14-27, BWG was greater (P < 0.05) in chicks fed diets supplemented 
with either GAA (11% higher) or Cre (PC1; 8% higher) compared with the salmon protein-
containing diet (PC2). There were no effects of dietary supplementation on feed intake during 
any feeding period in this study. 
Mortality-corrected gain:feed ratio was increased (P < 0.05) by addition of 0.12% GAA 
as compared with the NC diet from study d 0-14 and d 14-27. Supplementation of Cre increased 
(P < 0.05) G:F by 6, 4, and 4%, respectively, in the starter, grower, and overall periods as 
compared with the NC diet. While the salmon protein-containing diet (PC2) elicited superior G:F 
relative to all other treatments d 0-14, it also produced the lowest G:F for d 14-27 and d 0-27. 
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Overall, only the Cre-supplemented diet (PC1) increased (P < 0.05) G:F during the entire 27-day 
feeding study compared with the NC diet.  
Tissue Analysis. Supplementation of 0.12% GAA increased (P < 0.05) absolute PCr 
concentrations by 26% compared with the NC diet, and 0.12% GAA supplementation elicited 
PCr concentrations that were not different from either the PC1 or PC2 diets. The relative ratio of 
PCr:ATP was increased (P < 0.05) by 24% due to 0.12% GAA supplementation compared with 
the NC diet. Muscle tCre concentrations were increased (P < 0.05) by 18% due to 0.12% GAA 
supplementation relative to the NC diet. Supplementation of GAA at 0.06% elicited comparable 
tCre concentrations compared with the PC2 diet, but caused a reduced (P < 0.05) concentration 
of PCr as a proportion of tCre when compared with all other treatments.  
Discussion 
The present studies were designed to test the efficacy of GAA for supporting growth and 
improve muscle phosphagen status in fast-growing broiler chicks fed either Arg-deficient or Arg-
adequate diets based on practical ingredients. When GAA was supplemented in Arg-deficient 
diets, G:F increased markedly, such that diets containing 0.12% GAA elicited growth 
performance responses that were overall equivalent to the Arg-adequate PC diet in Study 1. 
Moreover, responses due to GAA were evident in muscle phosphagen concentrations as GAA-
supplemented diets caused PCr and tCre concentrations to meet or exceed those of the Arg-
adequate PC diet. In Arg-adequate diets, GAA supplementation also markedly increased G:F, 
such that diets containing 0.12% GAA elicited growth performance responses that were overall 
equivalent to the Cre-supplemented and salmon protein-supplemented PC diets. Moreover, 
responses due to GAA were evident in muscle phosphagen concentrations as 0.12% GAA 
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supplementation caused the PCr and tCre concentrations to meet or exceed those of the Cre-
supplemented and salmon protein-supplemented PC diets. These observations provide clear and 
direct evidence of GAA efficacy in terms of growth performance and muscle phosphagen status 
in broiler chicks fed practical Arg-deficient and Arg-adequate diets. 
 Improvements in growth performance when GAA is added to Arg-deficient diets are in 
agreement with data from Savage and O’Dell (1960) and Dilger et al. (2013). Unlike previous 
observations, however, supplementation of 0.12% GAA elicited both final BW and overall BWG 
improvements that were greater than the NC diet and equal to the PC diet. Moreover, G:F was 
improved as observed previously (Dilger et al., 2013). Our data strongly indicate an Arg-sparing 
effect (Almquist et al., 1941), which would allow Arg to be used for functions other than Cre 
synthesis, most notably muscle growth (Edwards Jr. et al., 1958). In general, GAA restored 
growth performance of birds receiving Arg-deficient diets containing practical ingredients 
common to the U.S. poultry industry. 
 Supplementation of 0.12% GAA increased concentrations of Cre-related metabolites in 
chicken breast muscle, with PCr and tCre concentrations increasing 66 and 49%, respectively, 
compared with the NC diet in Study 1. When compared with the PC diet, PCr and tCre 
concentrations due to 0.12% GAA supplementation were comparable, with 0.18% GAA 
increasing concentrations of these metabolites even further. These muscle phosphagen outcomes 
concur with observations from Michiels et al. (2012), who reported increases in breast muscle 
Cre concentrations with GAA supplementation. Because of the tandem increases in muscle PCr 
and tCre concentrations, we can assume that dietary GAA is successfully absorbed and 
metabolized to Cre in the broiler chicken (Wyss and Kaddurah-Daouk, 2000), and when 
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combined with the increase in growth performance, these observations indicate that GAA 
supplementation spares Arg from Cre synthesis. 
 Muscle PCr and tCre concentrations increased by 26 and 18%, respectively, due to 
supplementation of 0.12% GAA to the Arg-adequate diet when compared with the NC diet; these 
observations are also supported by recent research from Michiels et al. (2012). The increase in 
muscle metabolites, especially PCr and the PCr:ATP ratio, indicates that potential for PCr to 
regenerate ATP is increased, and thus, there appears to be an increased potential for energy 
expenditure in chickens consuming supplemental GAA. This likely occurs because GAA 
supplementation circumvents the down-regulation of AGAT caused by Cre (Wyss and 
Kaddurah-Daouk, 2000), and because the production of Cre from GAA is unregulated and 
continues until all GAA is consumed or excreted (da Silva et al., 2009). Supplemental GAA 
bypasses enzymatic regulation and permits increased concentrations of Cre-related metabolites in 
muscle, which is a unique outcome for this nutritional additive. In this way, tCre and PCr 
concentrations increase the overall potential for muscle energy homeostasis (Guimarães-Ferreira, 
2014), thereby allowing for ATP to be consumed at a higher rate in support of improved 
metabolic function. 
 When 0.12% GAA was supplemented to the Arg-adequate diet, G:F decreased 3% 
relative to the NC diet. This is in agreement with results of research conducted by Michiels et al. 
(2012) and Mousavi et al. (2013), who reported that feed efficiency was improved by 2 and 5%, 
respectively, when added to Arg-adequate diets. Because all diets in Study 2 were Arg-adequate, 
there was theoretically no Arg to be spared by GAA for protein accretion. Because GAA is 
converted to Cre via a methyltransferase step (Wyss and Kaddurah-Daouk, 2000), and both 
muscle PCr and tCre concentrations increased due to GAA supplementation, it is assumed that 
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GAA was synthesized to Cre with high efficacy, thereby producing results very similar to direct 
Cre supplementation. The advantage of using GAA, however, is that this chemically-synthesized 
metabolite is cheaper to produce and more stable than creatine monohydrate when used in broiler 
diets. 
 Both studies resulted in improvements in BWG and PCr:ATP ratios with 0.12% GAA 
supplementation. In an Arg-deficient diet, GAA is likely alleviating the Arg deficiency by 
sparing Arg for use in lean tissue accretion and increasing BWG (Dilger et al., 2013). In the Arg-
adequate diet, however, the rate of muscle protein synthesis should be equivalent because all 
diets contained adequate quantities of Arg, yet muscle concentrations of Cre-related metabolites 
continued to increase due to GAA supplementation. While that did not manifest as an 
improvement in BWG in our study, this phenomenon has been purported to increase muscle 
growth (Ingwall, 1976; Ingwall and Wildenthal, 1976). Whereas 0.12% GAA supplementation 
elicited increases in the PCr:ATP ratio in both Arg-deficient and Arg-adequate diets, 
improvements in the Arg-deficient diet were three times greater than in the Arg-adequate diet. 
With either dietary Arg status, GAA supplementation increased the concentration of Cre 
observed in the muscle, and this effect was predominantly through alteration of PCr 
concentrations. However, improvements in PCr:ATP ratio due to 0.12% GAA supplementation 
were greater for the Arg-deficient NC diet (1.45) than for the Arg-adequate NC diet (2.57), 
thereby directly implicating mild Arg-deficiency in decreased muscle phosphagen 
concentrations. 
Overall, we conclude that GAA is capable of sparing dietary Arg when broiler chicks are fed 
either Arg-deficient or Arg-adequate diets based on practical ingredients. From these studies, we 
conclude that 0.12% GAA supplementation is the most effective level of supplementation, such 
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that growth performance and Cre-related metabolites were superior to those elicited by the NC 
diets and equivalent to the PC diets. Future studies should focus on dose-dependent changes in 
AGAT activity to better quantify the Arg-sparing effects of GAA. Moreover, investigating 
whether GAA supplementation alters muscle protein synthesis in vivo is warranted, especially in 
direct relation to Cre supplementation. 
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Tables 
Table 4.1. Formulation and calculated nutrient composition for basal diets 1
 Study 1  Study 2 
Ingredient, % Starter Grower 
 Starter 
NC 
Starter 
PC2 
Grower 
NC 
Grower 
PC2 
Corn 53.99 55.35 54.51 58.63 59.02 62.89
Soybean Meal 17.00 11.20 35.53 24.91 30.74 20.35
DDGS 10.00 12.00 - - - -
Corn Gluten Meal 8.50 10.60 - - - -
Salmon Protein - - 0.00 7.00 0.00 7.00
Soy Oil 3.40 4.52 4.25 3.34 5.03 4.16
Salt 0.40 0.40 0.40 0.40 0.40 0.40
Limestone 1.45 1.30 1.35 1.35 1.30 1.30
Dicalcium Phosphate 2.00 1.75 2.00 2.00 1.75 1.75
Vitamin Premix2 0.20 0.20 0.20 0.20 0.20 0.20
Mineral Premix3 0.15 0.15 0.15 0.15 0.15 0.15
Choline Chloride 0.32 0.32 0.25 0.25 0.25 0.25
L-Lysine HCl 0.73 0.68 0.27 0.39 0.22 0.33
DL-Methionine 0.30 0.20 0.35 0.37 0.28 0.30
L-Isoleucine 0.12 0.06 0.00 0.12 0.00 0.12
L-Threonine 0.27 0.18 0.19 0.24 0.13 0.17
L-Tryptophan 0.05 0.05 - - - -
L-Valine 0.12 0.04 0.05 0.15 0.03 0.13
Inert Silica Sand 1.00 1.00 0.50 0.50 0.50 0.50
   
Proximate Composition   
 Crude Protein, % 22.0 21.0 22.0 23.5 20.0 21.6
 Calcium, % 1.07 0.94 1.06 1.04 0.97 0.95
 Phosphorus (total), % 0.75 0.69 0.74 0.77 0.68 0.70
 Phosphorus (available), % 0.51 0.46 0.49 0.55 0.44 0.50
 AMEN, kcal/kg 3,073 3,199 3,050 3,050 3,150 3,150
   
Digestible Amino Acids, %4   
 Arg 0.97 0.84 1.32 1.29 1.19 1.16
 Ile 0.86 0.76 0.82 0.82 0.74 0.74
 Leu 2.26 2.26 1.69 1.53 1.58 1.43
 Lys 1.27 1.11 1.26 1.26 1.11 1.11
 Met 0.65 0.56 0.65 0.69 0.56 0.60
 Met+Cys 0.95 0.85 0.95 0.95 0.84 0.84
 Thr 0.89 0.77 0.89 0.89 0.76 0.76
 Trp 0.21 0.18 0.23 0.22 0.21 0.20
 Val 0.96 0.85 0.95 0.95 0.85 0.85
1NC = negative control, PC2 = salmon protein-containing positive control. 
2Provided per kg of diet: retinyl acetate, 4,400 IU; cholecalciferol, 25 g; DL-ɑ- tocopheryl acetate, 11 IU; vitamin 
B12, 0.01 mg; riboflavin, 4.41 mg; D-Ca-pantothenate, 10 mg; niacin, 22 mg; menadione sodium bisulfite, 2.33 mg. 
3Provided as milligrams per kg of diet: Mn, 75 from MnO; Fe, 75 from FeSO4 • 7H2O; Zn, 75 from ZnO; Cu, 5 from 
CuSO4 • 5H2O; I, 0.75 from ethylene diamine dihydroiodide; Se, 0.1 from Na2SeO3. 
4Acquired from AMINODat® 4.0 (Evonik Industries AG, Hanau-Wolfgang, Germany). 
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 Table 4.2. Analyzed composition of dietary treatments and ingredient (%, as-is basis)1 
 Study 12   Study 23 
 NC PC  NC PC1 PC24  Salmon5 
Protein Nutrient Starter Grower Starter Grower  Starter Grower Starter Grower Starter Grower  
Crude Protein 22.56 23.55 23.55 21.33 22.6 19.9 23.2 20.6 24.1 21.8 82.8
Crude Fat 6.9 6.8 6.8 8.1 7.0 7.1 6.7 7.8 6.3 7.6 2.67
Crude Fiber 2.8 2.7 2.7 2.9 2.9 2.3 2.7 2.3 1.9 1.9 1.20
Ash 6.5 6.1 6.1 5.8 6.4 6.0 6.0 6.2 6.5 6.2 13.2
    
Amino Acids6    
Essential    
Arg 1.05 0.98 1.47 1.25 1.54 1.31 1.45 1.36 1.47 1.31 4.98
His 0.51 0.48 0.52 0.47 0.58 0.53 0.54 0.54 0.49 0.47 1.03
Ile 0.95 0.87 0.92 0.85 0.97 0.85 0.89 0.87 0.86 0.81 1.15
Leu 2.36 2.47 2.30 2.49 2.01 1.79 1.89 1.83 1.70 1.56 2.30
Lys 1.35 1.21 1.43 1.20 1.42 1.23 1.38 1.27 1.36 1.20 2.91
Met 0.68 0.56 0.66 0.58 0.61 0.59 0.66 0.61 0.68 0.62 1.37
Phe 1.09 1.08 1.08 1.08 1.17 1.01 1.10 1.03 0.97 0.85 1.56
Thr 0.98 0.93 0.99 0.87 0.97 0.84 0.98 0.87 0.96 0.84 1.96
Val 1.05 0.98 1.07 0.96 1.13 0.97 1.06 0.99 1.04 0.95 1.65
Non-Essential    
Ala 1.34 1.37 1.31 1.37 1.12 1.03 1.06 1.05 1.29 1.24 6.09
Asp 1.69 1.58 1.72 1.54 2.38 2.04 2.23 2.12 2.00 1.82 4.75
Cys 0.36 0.35 0.36 0.35 0.39 0.35 0.36 0.36 0.31 0.28 0.21
Glu 3.88 3.86 3.84 3.83 4.19 3.64 3.95 3.75 3.63 3.27 7.58
Gly 0.74 0.70 0.75 0.68 0.94 0.81 0.89 0.83 1.69 1.61 14.37
Pro 1.49 1.59 1.47 1.57 1.36 1.25 1.27 1.28 1.50 1.45 6.31
Ser 1.01 0.99 1.00 0.99 1.11 1.00 1.06 1.03 1.02 0.95 2.99
1NC = negative control treatment, PC = positive control treatment. 
2Basal diet formulated to contain 1.08% total Arg (0.97% digestible Arg) and 0.95% total Arg (0.84% digestible Arg) in the starter and grower phases, 
respectively.  
3Basal diet formulated to contain 1.42% total Arg (1.32% digestible Arg) and 1.28% total Arg (1.19% digestible Arg) in the starter and grower phases, 
respectively. 
4Basal diet formulated to contain 1.42% total Arg (1.29% digestible Arg) and 1.28% total Arg (1.16% digestible Arg) in the starter and grower phases, 
respectively. 
5Salmon protein is a commercially available product called Lipromar Salmon Protein. 
6Amino acid values standardized to a dry matter content of 88%. 
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Table 4.3. Growth performance of chicks fed Arg-deficient diets (Study 1)1 
 Dietary Treatment2
Variable NC 0.06% GAA 0.12% GAA 0.18% GAA PC  SEM 
Body weight, g        
 d 0 33.2 33.2 33.2 33.2 33.2  0.01 
 d 14 259.5 269.2 273.1 262.9 273.7  5.13 
 d 28 950.8a 987.9abc 1,010.4bc 982.3ab 1,042.4c   19.83 
Daily BW gain, g/chick        
 d 0-14 16.2 16.9 17.1 16.4 17.2  0.37 
 d 14-28 49.4a 51.0a 52.6ab 51.2a 54.8b  1.18 
 d 0-28 32.8a 34.1abc 34.9bc 33.9ab 36.0c  0.71 
Daily feed intake, g/chick        
 d 0-14 23.8 23.5 22.5 22.4 22.9  0.51 
 d 14-28 76.0 75.6 76.1 72.5 77.6  1.27 
 d 0-28 49.4 48.2 48.5 47.0 49.5  0.80 
Gain:feed, g/kg        
 d 0-14 675.3a 715.5b 749.5c 730.2bc 749.7c  10.03 
 d 14-28 643.3a 661.0a 680.8b 685.8b 706.0c  7.14 
 d 0-28 646.0a 663.7a 696.6bc 685.3ab 712.6c  8.79 
Mortality, # of chicks        
 d 0-14 3 3 5 2 5   
 d 14-28 2 5 1 5 1   
 d 0-28 5 8 6 7 6   
a-dMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are means of 12 replicate pens of 6 chicks during the feeding period 2-to-30 d post-hatch. Arg = arginine, BW = body 
weight, GAA = guanidinoacetic acid, NC = negative control treatment, PC = positive control treatment.  
2Basal diet formulated to contain 1.08% total Arg (0.97% digestible Arg) and 0.95% total Arg (0.84% digestible Arg) in the starter 
and grower phases, respectively. 
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Table 4.4. Muscle analyses of creatine-related metabolites of chicks fed Arg-deficient diets (Study 1)1 
 
Dietary Treatment2   
Variable NC 0.06% GAA 0.12% GAA 0.18% GAA PC  SEM 
ATP, mmol/kg DW 35.93 36.90 34.40 35.84 33.73  0.90 
PCr, mmol/kg DW 52.81a 62.42a 87.69b 108.17c 87.60b  4.25 
PCr:ATP ratio 1.45a 1.72a 2.56b 3.02c 2.62b  0.12 
Free Cre, mmol/kg DW 35.64a 39.88a 43.85ab 47.11b 51.73b  3.39 
Total Cre, mmol/kg DW3 88.45a 102.29b 131.54c 155.28d 139.33c  4.33 
PCr:total Cre, % 58.93 61.37 66.80 69.68 62.69  2.96 
a-dMeans within a row lacking a common superscript letter differ (P < 0.05). 
1ATP = adenosine triphosphate, Cre = creatine, DW = dry weight, GAA = guanidinoacetic acid, PCr = phosphocreatine, NC = 
negative control treatment, PC = positive control treatment 
2Basal diet formulated to contain 1.08% total Arg (0.97% digestible Arg) and 0.95% total Arg (0.84% digestible Arg) in the starter 
and grower phases, respectively. 
3Calculated as PCr plus free Cre. 
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Table 4.5. Growth performance of chicks fed Arg-adequate diets (Study 2)1 
 Dietary Treatment2
Variable NC 0.06% GAA 0.12% GAA PC13 PC24  SEM 
Body weight, g        
 d 0 34.3 34.3 34.3 34.3 34.3  0.24 
 d 14 431.1 438.7 449.3 440.5 448.4  9.42 
 d 27 1,418.1 1,440.4 1,490.2 1,451.3 1,378.3  26.81 
Daily BW gain, g/chick        
 d 0-14 28.4 28.9 29.6 29.0 29.6  0.67 
 d 14-27 75.6ab 76.9b 79.2b 77.7b 71.5a  1.51 
 d 0-27 51.3 52.1 53.9 52.5 51.4  1.21 
Daily feed intake, g/chick        
 d 0-14 36.7 36.0 37.3 35.2 33.7  0.87 
 d 14-27 97.1 96.0 100.2 95.5 94.1  1.76 
 d 0-27 66.6 64.5 67.8 65.0 62.8  1.32 
Gain:feed, g/kg        
 d 0-14 772.6a 785.4ab 801.3bc 818.4c 851.3d  9.55 
 d 14-27 719.5a 727.9ab 738.7bc 746.0c 703.7a  6.10 
 d 0-27 729.8ab 727.3a 748.5bc 759.9c 740.2abc  7.01 
Mortality, # of chicks        
 d 0-14 1 7 4 1 7   
 d 14-27 2 5 3 2 1   
 d 0-27 3 12 7 3 8   
a-dMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are means of 12 replicate pens of 6 chicks during the feeding period 2-to-29 d post-hatch.  Arg = arginine, BW = body 
weight, GAA = guanidinoacetic acid, NC = negative control treatment.  
2Basal diet formulated to contain 1.42% total Arg (1.32% digestible Arg) and 1.28% total Arg (1.19% digestible Arg) in the starter 
and grower phases, respectively. 
3Arg-adequate diet supplemented with 0.12% creatine monohydrate. 
4Basal diet formulated to contain 1.42% total Arg (1.29% digestible Arg) and 1.28% total Arg (1.16% digestible Arg) in the starter 
and grower phases, respectively. This Arg-adequate diet was supplemented with 7.0% salmon protein to achieve 0.12% digestible 
creatine to match PC1 diet. 
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Table 4.6. Muscle analyses of creatine-related metabolites fed Arg-adequate diets (Study 2)1 
 Dietary Treatment2
Variable NC 0.06% GAA 0.12% GAA PC13 PC24  SEM 
ATP, mmol/kg DW 27.71 28.36 27.84 30.04 27.73  1.14 
PCr, mmol/kg DW 70.27a 65.40a 88.44b 96.24b 86.95b  5.75 
PCr:ATP ratio 2.57a 2.30a 3.18b 3.23b 3.11b  0.18 
Free Cre, mmol/kg DW 58.30a 88.19b 63.31a 76.06b 79.37b  4.99 
Total Cre, mmol/kg DW5 128.57a 153.60bc 151.74b 172.30d 166.32cd  4.71 
PCr:total Cre, % 54.66b 41.92a 58.28b 55.83b 51.66b  3.28 
a-dMeans within a row lacking a common superscript letter differ (P < 0.05). 
1ATP = adenosine triphosphate, Cre = creatine, DW = dry weight, GAA = guanidinoacetic acid, NC = negative control 
treatment, PCr = phosphocreatine. 
2Basal diet formulated to contain 1.42% total Arg (1.32% digestible Arg) and 1.28% total Arg (1.19% digestible Arg) in the 
starter and grower phases, respectively. 
3Arg-adequate diet supplemented with 0.12% creatine monohydrate. 
4Basal diet formulated to contain 1.42% total Arg (1.29% digestible Arg) and 1.28% total Arg (1.16% digestible Arg) in the 
starter and grower phases, respectively. This Arg-adequate diet was supplemented with 7.0% salmon protein to achieve 0.12% 
digestible creatine to match PC1 diet. 
5Calculated as PCr plus free Cre. 
 
  
 
